Ensembl_ID	Gene_symbol	logFC	FDR	Comparison	LncBook ID	Type	Conservation	miRNA	GWAS	nearest PC	Top correlated gene
ENSG00000183784	DOCK8-AS1	6.575402157	0.001039376	Normal vs Doxo-treated	HSALNG0069528	anti_sense	Q75	NA	-	ZNG1A	TNMD
ENSG00000215458	AATBC	6.863742163	0.015035411	Normal vs Doxo-treated	HSALNG0133454	anti_sense	Not conserved	hsa-miR-6089	-	CSTB	TNMD
ENSG00000248362	ENSG00000248362	5.133765738	0.043528812	Normal vs Doxo-treated	HSALNG0045685	intronic_sense	Not conserved	NA	NA	C5orf46	TNMD
ENSG00000274238	ENSG00000274238	5.954392623	0.024838606	Normal vs Doxo-treated	HSALNG0035787	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3187-3p,hsa-miR-6089	Body height,Lymphocyte count,Leukocyte count,Calcium measurement,Dna methylation,Stromal cell-derived factor 1 alpha measurement,Response to bupropion,Idiopathic pulmonary fibrosis,Insomnia measurement,Age at onset,Trans fatty acid measurement; Trans/cis-18:2 fatty acid measurement,Response to trauma exposure; Post-traumatic stress disorder symptom measurement,-	MMRN1	TNMD
ENSG00000198358	ENSG00000198358	6.261601054	0.009855901	Normal vs Doxo-treated	HSALNG0007881	anti_sense	Not conserved	hsa-miR-6089	Granulocyte count,-	LY9	TNMD
ENSG00000253930	TNFRSF10A-AS1	4.072962743	0.039692406	Normal vs Doxo-treated	HSALNG0150163	anti_sense	Not conserved	NA	NA	CHMP7	TNMD
ENSG00000265408	ENSG00000265408	6.98113777	0.002512114	Normal vs Doxo-treated	HSALNG0112137	sense	Q90	NA	-	CES3	TNMD
ENSG00000286981	ENSG00000286981	5.536268503	0.041414599	Normal vs Doxo-treated	NA	NA	NA	NA	NA	PCGF5	TNMD
ENSG00000204148	LINC00474	5.75445904	0.028051961	Normal vs Doxo-treated	HSALNG0073965	integenic	Q75	hsa-miR-6089	Sporadic amyotrophic lateral sclerosis	ASTN2	TNMD
ENSG00000249267	LINC00939	5.65365805	0.033453669	Normal vs Doxo-treated	HSALNG0094921	integenic	Q50	NA	Interleukin-1 beta measurement,Protein measurement	DHX37	TNMD
ENSG00000223883	LINC01707	5.149216819	0.032191273	Normal vs Doxo-treated	HSALNG0004345	integenic	Q50	hsa-miR-619-5p,hsa-miR-3190-5p	Risk-taking behaviour,Mathematical ability,Femoral neck bone mineral density,Self reported educational attainment; Psoriasis; Mathematical ability,Low density lipoprotein cholesterol measurement,Susceptibility to urinary tract infection measurement,Response to polyunsaturated fatty acid supplementation; Delta-5 desaturase measurement,Fev/fec ratio; Response to bronchodilator,-	LRRC7	TNMD
ENSG00000205015	LINC02138	4.551339847	0.017386313	Normal vs Doxo-treated	HSALNG0144825	integenic	Not conserved	hsa-miR-762,hsa-miR-6089	Suntan,-	ACSF3	TNMD
ENSG00000273348	ENSG00000273348	5.539156445	0.040003641	Normal vs Doxo-treated	HSALNG0120361	integenic	Q50	NA	Low density lipoprotein cholesterol measurement,Triglyceride measurement,Red blood cell distribution width,Lysophosphatidylcholine measurement,Benign prostatic hyperplasia; Lower urinary tract symptom,-	CTAGE1	TNMD
ENSG00000285771	ENSG00000285771	7.508831076	0.007282469	Normal vs Doxo-treated	HSALNG0047876	integenic	Not conserved	hsa-miR-4472,hsa-miR-6803-5p	Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio	SSR1	TNMD
ENSG00000289911	ENSG00000289911	7.171277392	0.002512114	Normal vs Doxo-treated	HSALNG0050962	integenic	Q50	NA	Respiratory system disease,-	LGSN	TNMD
ENSG00000267943	ENSG00000267943	5.751612015	0.031601543	Normal vs Doxo-treated	HSALNG0145791	integenic	Not conserved	NA	NA	ERVV-1	TNMD
ENSG00000268621	IGFL2-AS1	5.336648626	0.049927633	Normal vs Doxo-treated	HSALNG0126652	anti_sense	Not conserved	hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-1231,hsa-miR-1202,hsa-miR-4318,hsa-miR-4274,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-4652-5p,hsa-miR-4691-5p,hsa-miR-6512-3p,hsa-miR-6728-3p,hsa-miR-6756-3p,hsa-miR-6791-3p,hsa-miR-6799-5p	Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement,-	IGFL3	TNMD
ENSG00000237863	IRS4-AS1	5.542094261	0.041829311	Normal vs Doxo-treated	HSALNG0139480	anti_sense	Q90	hsa-miR-4277,hsa-miR-6838-5p	NA	COL4A5	TNMD
ENSG00000250302	LINC01618	6.026418488	0.019022301	Normal vs Doxo-treated	HSALNG0034427	integenic	Q50	NA	-	RASL11B	TNMD
ENSG00000260943	LINC02555	5.762754711	0.032196047	Normal vs Doxo-treated	HSALNG0090479	integenic	Q50	NA	Inflammatory bowel disease,Low density lipoprotein cholesterol measurement,Mean platelet volume; Platelet count,Bacteriemia,-	SLC2A13	TNMD
ENSG00000287709	ENSG00000287709	5.545366164	0.047964439	Normal vs Doxo-treated	HSALNG0042015	integenic	Q75	NA	-	GPBP1	TNMD
ENSG00000239593	ENSG00000239593	6.444321892	0.021561955	Normal vs Doxo-treated	HSALNG0074167	anti_sense	Not conserved	NA	-	STOM	TNMD
ENSG00000290829	ENSG00000290829	6.265896156	0.009967594	Normal vs Doxo-treated	NA	NA	NA	NA	NA	DEFB134	TNMD
ENSG00000261572	ENSG00000261572	5.648017765	0.035627603	Normal vs Doxo-treated	HSALNG0024984	anti_sense	Q50	NA	NA	OSBPL10	TNMD
ENSG00000289991	ENSG00000289991	5.841759711	0.041414599	Normal vs Doxo-treated	NA	NA	NA	NA	NA	DUS2	TNMD
ENSG00000260581	ENSG00000260581	5.957410186	0.030069798	Normal vs Doxo-treated	HSALNG0045906	anti_sense,sense	Q50	hsa-miR-433-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4800-3p	Folic acid measurement,Glycine measurement,Skin aging measurement,Pyroglutamine measurement,Protein measurement,Basophil count; Basophil percentage of leukocytes,Basophil count,Basophil percentage of leukocytes,Basophil percentage of granulocytes,Medial orbital frontal cortex volume measurement; Caudal anterior cingulate cortex volume measurement,Stroke,Body height,Fev/fec ratio; Response to bronchodilator,-,Colorectal health,Ischemic stroke,Adolescent idiopathic scoliosis,Body mass index	G3BP1	TNMD
ENSG00000288765	ENSG00000288765	8.110723886	0.005516918	Normal vs Doxo-treated	NA	NA	NA	NA	NA	PCDH17	TNMD
ENSG00000289168	ENSG00000289168	6.749053456	0.004841654	Normal vs Doxo-treated	NA	NA	NA	NA	NA	KATNAL2	TNMD
ENSG00000233154	LINC01762	4.081300746	0.043357578	Normal vs Doxo-treated	HSALNG0006329	sense	Q50	hsa-miR-619-5p,hsa-miR-670-5p,hsa-miR-920,hsa-miR-3160-5p,hsa-miR-4286,hsa-miR-4447,hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6132,hsa-miR-6776-5p	Covid-19,Diastolic blood pressure,Cystatin c measurement,Leukocyte count; Neutrophil count,Creatinine measurement,Systemic lupus erythematosus,Primary biliary cirrhosis,Response to sulfasalazine; Drug-induced agranulocytosis,Stressful life event measurement; Depressive symptom measurement,-	CD58	TNMD
ENSG00000235538	ENSG00000235538	6.987332482	0.003420585	Normal vs Doxo-treated	HSALNG0054960	integenic	Not conserved	hsa-miR-504-3p	NA	QKI	TNMD
ENSG00000251381	LINC00958	6.647326655	0.007562404	Normal vs Doxo-treated	HSALNG0082749	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-3178,hsa-miR-1268b,hsa-miR-4463,hsa-miR-1199-5p,hsa-miR-6089,hsa-miR-6510-5p,hsa-miR-6763-5p,hsa-miR-7111-3p	Fat body mass,Obesity,-	BTBD10	TNMD
ENSG00000290319	ENSG00000290319	5.946468284	0.018683097	Normal vs Doxo-treated	HSALNG0061314	integenic	Q90	hsa-miR-3180-3p,hsa-miR-3180,hsa-miR-6816-5p	-	NRF1	TNMD
ENSG00000261183	SPINT1-AS1	4.441367789	0.032507801	Normal vs Doxo-treated	HSALNG0105295	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1178-5p,hsa-miR-5787,hsa-miR-6089,hsa-miR-6780a-3p	Blood protein measurement,-	PPP1R14D	TNMD
ENSG00000289501	ENSG00000289501	8.370367309	0.000539725	Normal vs Doxo-treated	NA	NA	NA	NA	NA	POU3F2	TNMD
ENSG00000225039	LINC01058	4.121106515	0.032148128	Normal vs Doxo-treated	HSALNG0096114	integenic	Q50	hsa-miR-646,hsa-miR-4505	NA	HMGB1	TNMD
ENSG00000250532	ENSG00000250532	3.866113583	0.033453669	Normal vs Doxo-treated	HSALNG0035213	integenic	Q50	NA	NA	BTC	TNMD
ENSG00000227748	ENSG00000227748	5.927673078	0.000294665	Normal vs Doxo-treated	HSALNG0054151	integenic	Q50	NA	-	ADGB	TNMD
ENSG00000290097	ENSG00000290097	5.653656977	0.033453669	Normal vs Doxo-treated	HSALNG0022818	integenic	Q50	hsa-miR-619-5p	Seasonal gut microbiome measurement,Carpal tunnel syndrome,-	FBXO36	TNMD
ENSG00000235615	ENSG00000235615	5.754459237	0.028051961	Normal vs Doxo-treated	HSALNG0146599	integenic	Not conserved	NA	NA	ANKRD30BL	TNMD
ENSG00000287381	ENSG00000287381	6.821641006	0.04749355	Normal vs Doxo-treated	HSALNG0121537	intronic_antisense	Q50	NA	NA	MRO	TNMD
ENSG00000253270	ENSG00000253270	4.592016686	0.015827865	Normal vs Doxo-treated	HSALNG0150155	anti_sense	Not conserved	hsa-miR-6796-3p	Response to antidepressant,Asparaginase hypersensitivity	INTS10	TNMD
ENSG00000279182	ENSG00000279182	7.59162851	0.001247746	Normal vs Doxo-treated	HSALNG0136279	anti_sense	Q75	hsa-miR-4632-3p,hsa-miR-5001-3p,hsa-miR-5589-5p,hsa-miR-6845-5p,hsa-miR-6893-3p	-	PPP6R2	TNMD
ENSG00000287054	ENSG00000287054	4.129700524	0.035366914	Normal vs Doxo-treated	HSALNG0148703	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089	NA	HSPA4	SCYL3
ENSG00000227906	SNAP25-AS1	6.521769188	0.006095524	Normal vs Doxo-treated	HSALNG0128611	integenic	Q50	NA	NA	MKKS	PNPLA4
ENSG00000286485	ENSG00000286485	5.762753288	0.032196047	Normal vs Doxo-treated	HSALNG0135243	anti_sense	Q75	NA	-	NCF4	CEACAM21
ENSG00000286409	ENSG00000286409	5.650877522	0.033290417	Normal vs Doxo-treated	HSALNG0077142	integenic	Not conserved	NA	-	EPC1	TKTL1
ENSG00000253394	LINC00534	5.53626656	0.041414599	Normal vs Doxo-treated	HSALNG0066871	integenic	Not conserved	hsa-miR-4430	NA	NECAB1	FMO3
ENSG00000235660	LINC00345	3.427465994	0.04413482	Normal vs Doxo-treated	HSALNG0097265	integenic	Not conserved	hsa-miR-6821-5p,hsa-miR-7109-5p	Ovarian carcinoma,Age at onset,-	VPS36	TFAP2B
ENSG00000287175	ENSG00000287175	5.530310478	0.02275397	Normal vs Doxo-treated	HSALNG0142491	integenic	Not conserved	hsa-miR-6089	Gut microbiome measurement,Mean corpuscular volume,-	PFKP	TFAP2B
ENSG00000254416	LINC02732	5.545360849	0.047964439	Normal vs Doxo-treated	HSALNG0087054	integenic	Q75	hsa-miR-4505	Cognition,Serum metabolite measurement; Coronary artery disease,Angina pectoris; Antithrombotic agent use measurement; Aspirin use measurement; Myocardial infarction,Angina pectoris; Vasodilators used in cardiac diseases use measurement; Aspirin use measurement,Body height,Coronary artery disease,-	FDX1	TFAP2B
ENSG00000242009	ENSG00000242009	6.246809591	0.025566332	Normal vs Doxo-treated	HSALNG0027097	integenic	Q90	NA	Grip strength measurement,Loneliness measurement,Chronotype measurement,Extraversion,Social interaction measurement; Loneliness measurement,Intelligence,-	CADM2	TFAP2B
ENSG00000288994	ENSG00000288994	5.64801821	0.035627603	Normal vs Doxo-treated	HSALNG0014301	sense	Not conserved	NA	Protein measurement,-	ATL2	TFAP2B
ENSG00000286339	ENSG00000286339	6.314301439	0.002719224	Normal vs Doxo-treated	HSALNG0053093	anti_sense	Q90	hsa-miR-4257,hsa-miR-4266	-	PLN	TFAP2B
ENSG00000273760	ENSG00000273760	6.31572746	0.023778773	Normal vs Doxo-treated	HSALNG0142768	integenic	Q50	NA	NA	FAM25C	TFAP2D
ENSG00000227484	ENSG00000227484	6.511615143	0.010441981	Normal vs Doxo-treated	HSALNG0136279	anti_sense	Q75	hsa-miR-4632-3p,hsa-miR-5001-3p,hsa-miR-5589-5p,hsa-miR-6845-5p,hsa-miR-6893-3p	-	PPP6R2	TFAP2D
ENSG00000285911	ENSG00000285911	8.38226226	0.000190488	Normal vs Doxo-treated	HSALNG0070297	integenic	Not conserved	NA	Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration	RPS6	TFAP2D
ENSG00000273784	ENSG00000273784	4.645822553	0.022169733	Normal vs Doxo-treated	HSALNG0097270	sense	Not conserved	NA	-	HNRNPA1L2	TFAP2D
ENSG00000285899	ENSG00000285899	6.420412391	0.03001461	Normal vs Doxo-treated	HSALNG0137522	integenic	Q75	hsa-miR-6895-5p	NA	MAOA	TFAP2D
ENSG00000236908	LINC02827	8.55103963	0.000182903	Normal vs Doxo-treated	HSALNG0088646	integenic	Q50	hsa-miR-4695-5p,hsa-miR-6791-3p	Glomerular filtration rate,-	TSPAN9	TFAP2D
ENSG00000226017	PRICKLE2-AS3	4.07923159	0.040992528	Normal vs Doxo-treated	HSALNG0026567	anti_sense	Q50	NA	Serum igg glycosylation measurement	ATXN7	PAX7
ENSG00000291144	ENSG00000291144	7.684952937	0.000733667	Normal vs Doxo-treated	HSALNG0082349	overlap_sense	Not conserved	NA	Lung carcinoma,Mean corpuscular hemoglobin concentration,Hip bone mineral density; Hip bone size,Diastolic blood pressure,-	OR52K1	NR1H4
ENSG00000230731	LINC02938	4.012823725	0.043249912	Normal vs Doxo-treated	HSALNG0096739	integenic	Q50	hsa-miR-874-3p,hsa-miR-6764-3p	Hair colour measurement,Forced expiratory volume; Fev/fec ratio,Balding measurement,Fev/fec ratio,Dupuytren contracture; Chronic obstructive pulmonary disease,Heel bone mineral density,Body height,Peripheral arterial disease; Traffic air pollution measurement,-	SMIM2	NR1H4
ENSG00000290695	ENSG00000290695	5.650877525	0.033290417	Normal vs Doxo-treated	HSALNG0087886	integenic	Not conserved	NA	Taurocholate measurement,-	OR8B8	NR1H4
ENSG00000269915	ENSG00000269915	5.650878718	0.033273116	Normal vs Doxo-treated	HSALNG0143112	anti_sense	Q50	hsa-miR-5787,hsa-miR-6793-3p	-	DEAF1	NR1H4
ENSG00000265073	ENSG00000265073	4.619874273	0.030869738	Normal vs Doxo-treated	HSALNG0115511	anti_sense	Q75	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-6089	Varicose veins,Reticulocyte measurement,-	TLCD1	NR1H4
ENSG00000259380	LINC02895	5.938635397	0.024774158	Normal vs Doxo-treated	HSALNG0105106	integenic	Q75	hsa-miR-103a-1-5p,hsa-miR-4535	Lycopene measurement,Femoral neck bone mineral density; Spine bone mineral density,Bone density,Body height,Tryptophan measurement,Self reported educational attainment; Mathematical ability,Chagas cardiomyopathy,Hypersomnia,Mathematical ability,Bipolar disorder,Lean body mass,Body weight,Fev/fec ratio; Response to bronchodilator,-	RASGRP1	NR1H4
ENSG00000286071	ENSG00000286071	5.542088783	0.041828943	Normal vs Doxo-treated	HSALNG0011461	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4257	Arterial stiffness measurement,Cotinine measurement,Adolescent idiopathic scoliosis,Serum alanine aminotransferase measurement,-	NA	NR1H4
ENSG00000287989	ENSG00000287989	6.479102605	0.016762958	Normal vs Doxo-treated	HSALNG0009497	integenic	Not conserved	NA	C-reactive protein measurement,Pulse pressure measurement; Neutrophil count,Response to antineoplastic agent; Response to cyclophosphamide,Cleft lip; Cleft palate,-	ATP6V1G3	NR1H4
ENSG00000224173	LINC02831	5.014422323	0.034196831	Normal vs Doxo-treated	HSALNG0015645	integenic	Q50	hsa-miR-210-5p	Bmi-adjusted waist-hip ratio,Lung carcinoma,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; Visceral adipose tissue measurement; Body height; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Body weight; Body mass index,Gastroesophageal reflux disease,Body mass index,Barrett's esophagus,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Peptic ulcer disease; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Gastroesophageal reflux disease,-	ETAA1	CLCA1
ENSG00000250891	LINC02208	5.858847422	0.024285718	Normal vs Doxo-treated	HSALNG0044371	integenic	Q75	NA	NA	DTWD2	CLCA1
ENSG00000287526	ENSG00000287526	5.864841463	0.033453669	Normal vs Doxo-treated	HSALNG0125469	integenic	Q50	NA	Fusiform gyrus volume measurement,-	PEPD	CLCA1
ENSG00000251450	RASGRF2-AS1	5.960660566	0.03690938	Normal vs Doxo-treated	HSALNG0043014	anti_sense	Q75	hsa-miR-6891-5p,hsa-miR-6893-3p	Risk-taking behaviour,Smoking status measurement,-	DHFR	CLCA1
ENSG00000226005	LINC02660	9.706444832	7.61e-05	Normal vs Doxo-treated	HSALNG0075747	integenic	Not conserved	hsa-miR-6089	NA	PFKP	C8B
ENSG00000272568	CPVL-AS2	6.24960606	0.020205555	Normal vs Doxo-treated	HSALNG0056940	anti_sense	Q50	hsa-miR-210-5p,hsa-miR-6089	Lobe attachment,Response to irinotecan,Neuropsychological test,-	CHN2	C8B
ENSG00000289540	ENSG00000289540	6.720952164	0.021601403	Normal vs Doxo-treated	HSALNG0041373	anti_sense,sense	Q50	NA	Ankylosing spondylitis,Complement component c7 measurement,Serum urea measurement,Urate measurement,Mental or behavioural disorder,Hematocrit; Hemoglobin measurement,Gastric carcinoma,Blood urea nitrogen measurement,Erythrocyte count,Red blood cell density measurement,-	TTC33	C8B
ENSG00000272078	ENSG00000272078	7.103455589	0.002060829	Normal vs Doxo-treated	HSALNG0000789	anti_sense	Q50	hsa-miR-505-3p	NA	PEX14	C8B
ENSG00000287165	ENSG00000287165	6.562434551	0.018987986	Normal vs Doxo-treated	HSALNG0018070	integenic	Not conserved	hsa-miR-619-5p	NA	SLC35F5	C8B
ENSG00000218018	RBM38-AS1	4.750065007	0.012340518	Normal vs Doxo-treated	HSALNG0146983	anti_sense	Q75	hsa-miR-4720-5p	Reticulocyte measurement,Myeloid white cell count,Neutrophil count,Reticulocyte count; Reticulocyte measurement,Reticulocyte count,Mean reticulocyte volume,-	HMGB1P1	C8B
ENSG00000290549	ENSG00000290549	4.081299612	0.043357578	Normal vs Doxo-treated	HSALNG0071491	integenic	Not conserved	hsa-miR-6089	NA	FOXD4L5	C8B
ENSG00000272841	MAP3K4-AS1	4.242250608	0.000218503	Normal vs Doxo-treated	NA	NA	NA	NA	NA	AGPAT4	ANK1
ENSG00000287021	ENSG00000287021	7.41192765	0.001802416	Normal vs Doxo-treated	HSALNG0037019	anti_sense	Q50	hsa-miR-1224-3p,hsa-miR-4505,hsa-miR-5589-5p	Serum igg glycosylation measurement,Mean corpuscular volume,Mean reticulocyte volume,Susceptibility to rubella infection measurement,Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration,Trans fatty acid measurement; Trans/trans-18:2 fatty acid measurement,-	MFSD8	CDH10
ENSG00000236719	OVAAL	5.655154273	0.002606667	Normal vs Doxo-treated	HSALNG0008817	integenic	Not conserved	NA	NA	XPR1	ADAM28
ENSG00000253695	PINX1-DT	4.541176715	0.023333657	Normal vs Doxo-treated	HSALNG0063393	anti_sense	Not conserved	hsa-miR-4478,hsa-miR-4632-3p,hsa-miR-6729-3p	-	C8orf74	GUCA2B
ENSG00000225172	ENSG00000225172	5.762763699	0.032213934	Normal vs Doxo-treated	HSALNG0009524	integenic	Not conserved	NA	-	PTPRC	GUCA2B
ENSG00000237074	LINC02942	5.417917297	0.0492219	Normal vs Doxo-treated	HSALNG0010093	integenic	Not conserved	hsa-miR-297	Blood protein measurement,Hypermetropia; Cognitive function measurement; Myopia,Posterior cortical atrophy; Complement decay-accelerating factor measurement,Abnormality of refraction; Refractive error	CD55	GUCA2B
ENSG00000257702	LBX2-AS1	3.359839356	0.00903798	Normal vs Doxo-treated	HSALNG0016063	anti_sense	Q90	hsa-miR-4492,hsa-miR-6726-5p	-	TTC31	NFE2L3
ENSG00000234956	LINC02539	7.043930651	0.008154197	Normal vs Doxo-treated	HSALNG0053785	integenic	Not conserved	NA	NA	OLIG3	NPFFR2
ENSG00000249421	ADAMTS19-AS1	5.542095082	0.041829311	Normal vs Doxo-treated	HSALNG0044748	anti_sense	Q50	hsa-miR-6877-3p	Intraocular pressure measurement,Energy intake,Cortical surface area measurement; Brain volume measurement; Cortical thickness,Protein measurement,Forced expiratory volume; Fev/fec ratio,Fev/fec ratio,Joint damage measurement,Body height,-	FBN2	NPFFR2
ENSG00000287969	ENSG00000287969	6.343166591	0.013160935	Normal vs Doxo-treated	HSALNG0078205	anti_sense	Q90	hsa-miR-4492	-	PHYHIPL	NPFFR2
ENSG00000230109	LINC02643	8.82074778	0.000142597	Normal vs Doxo-treated	HSALNG0076580	integenic	Q50	hsa-miR-619-5p,hsa-miR-378j,hsa-miR-6760-3p	-	NEBL	NPFFR2
ENSG00000189275	LINC01164	10.38996206	1.81e-06	Normal vs Doxo-treated	HSALNG0142896	integenic	Not conserved	NA	NA	BNIP3	NPFFR2
ENSG00000253824	ENSG00000253824	6.272818223	0.014114414	Normal vs Doxo-treated	HSALNG0067287	integenic	Q50	NA	NA	RNF19A	NPFFR2
ENSG00000245904	BTG1-DT	3.47965331	0.040232618	Normal vs Doxo-treated	HSALNG0143464	integenic	Not conserved	hsa-miR-7703	Eosinophil count; Eosinophil percentage of leukocytes,Covid-19,-	PLEKHG7	ZNF76
ENSG00000236671	PRKG1-AS1	3.509514437	0.01590506	Normal vs Doxo-treated	HSALNG0077999	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6510-5p	Eosinophilic esophagitis,Heel bone mineral density,Periodontitis,Dickkopf‐related protein 1 measurement,Blood protein measurement,Behcet's syndrome,Stressful life event measurement; Alcohol dependence measurement,-	MBL2	COL17A1
ENSG00000259869	ENSG00000259869	4.087231215	0.032191273	Normal vs Doxo-treated	HSALNG0077502	integenic	Not conserved	NA	-	ZNF33B	ADGRF5
ENSG00000248429	GASK1B-AS1	3.988874265	0.001197637	Normal vs Doxo-treated	HSALNG0038152	anti_sense,sense	Q50	hsa-miR-486-3p,hsa-miR-4466	Blood osmolality measurement,-	TMEM144	ABCC9
ENSG00000265728	ENSG00000265728	5.542089895	0.041828943	Normal vs Doxo-treated	HSALNG0120011	integenic	Not conserved	NA	3-hydroxypropylmercapturic acid measurement,-	NAPG	GUCY2C
ENSG00000291007	ENSG00000291007	5.769476171	0.046605412	Normal vs Doxo-treated	NA	NA	NA	NA	NA	CAV3	SCT
ENSG00000289578	ENSG00000289578	4.795675887	0.026517373	Normal vs Doxo-treated	HSALNG0060952	integenic	Q75	hsa-miR-6894-5p	Bmi-adjusted waist-hip ratio,Heel bone mineral density,Grip strength measurement,Protein measurement,-	FAM3C	CHAT
ENSG00000226644	ENSG00000226644	4.407934732	0.02009727	Normal vs Doxo-treated	HSALNG0128172	sense	Q75	hsa-miR-6085	Basal cell carcinoma,Diastolic blood pressure,Keratinocyte carcinoma,-	NA	CHAT
ENSG00000272081	FCHO2-DT	6.033567945	9.43e-05	Normal vs Doxo-treated	HSALNG0042600	anti_sense	Q75	hsa-miR-4466,hsa-miR-3960	Serum urea measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Calcium measurement,Heel bone mineral density,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Monocyte count,Mean reticulocyte volume; Mean corpuscular volume; Serum albumin measurement,-	ZNF366	TBX21
ENSG00000244040	IL12A-AS1	5.539154988	0.03987439	Normal vs Doxo-treated	HSALNG0030211	integenic	Not conserved	NA	NA	NA	ARHGEF10L
ENSG00000245928	SDAD1-AS1	5.653656988	0.033453669	Normal vs Doxo-treated	HSALNG0035291	anti_sense	Not conserved	NA	Lung carcinoma,Blood protein measurement,-	ART3	WSCD2
ENSG00000276436	ENSG00000276436	4.100510506	0.034804393	Normal vs Doxo-treated	HSALNG0097074	integenic	Q75	hsa-miR-885-3p,hsa-miR-6812-3p	-	ARL11	WSCD2
ENSG00000231394	ENSG00000231394	7.460641416	0.001218121	Normal vs Doxo-treated	HSALNG0058196	anti_sense	Q75	NA	Eye colour measurement,-	LANCL2	WSCD2
ENSG00000256422	LINC02552	5.856192759	0.022494495	Normal vs Doxo-treated	HSALNG0086855	integenic	Q50	hsa-miR-619-5p	Matrix metalloproteinase measurement,Allergic sensitization measurement,Self reported educational attainment,Matrix metalloproteinase 12 measurement,Mathematical ability,-	CASP12	WSCD2
ENSG00000254166	CASC19	4.266673265	0.02901269	Normal vs Doxo-treated	HSALNG0068428	integenic	Not conserved	hsa-miR-10226	Bmi-adjusted hip circumference	LRATD2	WSCD2
ENSG00000223646	ENSG00000223646	5.754459401	0.028051961	Normal vs Doxo-treated	HSALNG0060625	anti_sense	Q50	NA	-	LSMEM1	KCNQ2
ENSG00000287201	ENSG00000287201	5.769471339	0.046605412	Normal vs Doxo-treated	HSALNG0068614	anti_sense	Q50	NA	-	EFR3A	TYR
ENSG00000289885	ENSG00000289885	4.918937466	0.011895036	Normal vs Doxo-treated	HSALNG0029913	sense	Q75	hsa-miR-619-5p,hsa-miR-6803-5p	Lysophosphatidylcholine 20:5 measurement,Trauma exposure measurement,Lymphocyte count,Pr interval,Platelet count,Covid-19,Lysophosphatidylcholine 22:6 measurement,Cerebral amyloid deposition measurement,Hair color; Cutaneous melanoma,Lymphocyte percentage of leukocytes,-	RAP2B	TYR
ENSG00000290778	ENSG00000290778	5.841755036	0.041414599	Normal vs Doxo-treated	HSALNG0134828	anti_sense	Not conserved	NA	Reticulocyte count; Reticulocyte measurement,Reticulocyte measurement; Aspartate aminotransferase measurement,Pathological myopia,Reticulocyte count,Aspartate aminotransferase measurement,Heel bone mineral density,-	RFPL1	TYR
ENSG00000227253	ENSG00000227253	6.272817889	0.014114414	Normal vs Doxo-treated	HSALNG0077133	anti_sense	Q50	NA	Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,-	CCDC7	TYR
ENSG00000288755	ENSG00000288755	7.22754284	0.019175407	Normal vs Doxo-treated	HSALNG0142490	integenic	Q75	NA	NA	PFKP	TYR
ENSG00000256568	ENSG00000256568	5.53915587	0.039938769	Normal vs Doxo-treated	HSALNG0085610	integenic	Not conserved	hsa-miR-4485-5p	NA	P2RY2	CPB2
ENSG00000204661	C5orf60	7.13064163	0.003285157	Normal vs Doxo-treated	HSALNG0047097	integenic	Not conserved	hsa-miR-762,hsa-miR-4437,hsa-miR-5787,hsa-miR-6802-3p	NA	HNRNPH1	CPB2
ENSG00000256654	ENSG00000256654	5.53915585	0.039938769	Normal vs Doxo-treated	HSALNG0088766	integenic	Not conserved	NA	NA	KCNA1	CPB2
ENSG00000227258	SMIM2-AS1	3.509151784	0.039062654	Normal vs Doxo-treated	HSALNG0096738	integenic	Not conserved	NA	NA	NA	PREP
ENSG00000255571	MIR9-3HG	5.677152177	0.003432714	Normal vs Doxo-treated	HSALNG0108036	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1228-5p,hsa-miR-3178,hsa-miR-4529-5p,hsa-miR-4667-3p,hsa-miR-4710,hsa-miR-6089,hsa-miR-6736-5p,hsa-miR-6810-3p,hsa-miR-6816-5p,hsa-miR-6826-3p,hsa-miR-6887-3p	White matter microstructure measurement,Cortical surface area measurement; Cigarettes per day measurement,Mathematical ability,Body mass index,Comparative body size at age 10, self-reported,Dental caries; Dentures,-	FANCI	TMPRSS11E
ENSG00000227811	INKA2-AS1	3.906383407	0.015827865	Normal vs Doxo-treated	HSALNG0006073	intronic_antisense	Q90	hsa-miR-939-3p,hsa-miR-3178	Body mass index,Multisite chronic pain,-	DDX20	GMCL1
ENSG00000287990	ENSG00000287990	5.8682541	0.041828943	Normal vs Doxo-treated	HSALNG0144090	anti_sense	Not conserved	NA	Body mass index; Urate measurement	ABHD12B	GP6
ENSG00000233828	MIR4280HG	4.010567831	0.043541651	Normal vs Doxo-treated	HSALNG0043286	integenic	Q50	hsa-miR-6503-3p	NA	CCNH	PXN
ENSG00000250734	ENSG00000250734	6.19183009	0.011031839	Normal vs Doxo-treated	HSALNG0142346	anti_sense	Q90	hsa-miR-4472,hsa-miR-3960,hsa-miR-6803-5p,hsa-miR-8072	Headache,-	CELF3	SI
ENSG00000287555	ENSG00000287555	7.866818666	0.000645245	Normal vs Doxo-treated	HSALNG0148211	intronic_antisense	Q90	hsa-miR-6089	-	ARFIP1	SLC26A3
ENSG00000287561	ENSG00000287561	7.307527808	0.003935599	Normal vs Doxo-treated	HSALNG0146901	anti_sense	Not conserved	NA	Platelet crit	PDYN	SMPX
ENSG00000236501	ENSG00000236501	6.041536546	0.022494495	Normal vs Doxo-treated	HSALNG0020631	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1227-5p,hsa-miR-1236-3p,hsa-miR-4444,hsa-miR-6089,hsa-miR-6090	Alopecia; Androgenetic alopecia; Balding measurement,Red blood cell density measurement; Erythrocyte count,Red blood cell density measurement,Erythrocyte count,Alopecia; Androgenetic alopecia,Hematocrit,Sjogren syndrome,Hemoglobin measurement,Hematocrit; Hemoglobin measurement,Balding measurement,Alopecia,Memory performance,Velopharyngeal dysfunction,Pulse pressure measurement,Cirrhosis of liver; Non-alcoholic fatty liver disease,-	NFE2L2	SMPX
ENSG00000283286	ENSG00000283286	6.278002671	0.02060931	Normal vs Doxo-treated	HSALNG0041364	integenic	Not conserved	NA	Selective iga deficiency disease,Crohn's disease,Velopharyngeal dysfunction	PTGER4	SMPX
ENSG00000250041	ENSG00000250041	7.449970504	0.000280995	Normal vs Doxo-treated	HSALNG0082662	integenic	Q90	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6165	Heel bone mineral density,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,-	ZBED5	CRTAC1
ENSG00000258028	ENSG00000258028	5.845122563	0.033273116	Normal vs Doxo-treated	HSALNG0100313	integenic	Not conserved	NA	NA	FOXG1	CHRNA4
ENSG00000233290	ENSG00000233290	5.864842996	0.033453669	Normal vs Doxo-treated	HSALNG0004747	integenic	Q75	NA	Diabetic nephropathy,Selenium measurement,Vital capacity,-	TTLL7	EPPIN
ENSG00000272468	ENSG00000272468	3.318799421	0.016762958	Normal vs Doxo-treated	HSALNG0048836	integenic	Not conserved	NA	NA	H2BC11	PCSK1N
ENSG00000236700	LINC01010	6.09278716	0.003331709	Normal vs Doxo-treated	HSALNG0053623	integenic	Q50	hsa-miR-619-5p,hsa-miR-4267,hsa-miR-4430,hsa-miR-6089	Dental caries,-	TBPL1	MTFMT
ENSG00000259424	IRAIN	4.209198163	0.007659402	Normal vs Doxo-treated	HSALNG0108507	anti_sense	Q90	NA	Bmi-adjusted hip circumference,Parental genotype effect measurement; Birth weight,Birth weight; Serum gamma-glutamyl transferase measurement,-	PGPEP1L	SLC39A14
ENSG00000286050	ENSG00000286050	5.505589371	0.005561861	Normal vs Doxo-treated	HSALNG0140980	integenic	Q50	NA	NA	TGIF2LY	SULT2A1
ENSG00000255004	SLC1A2-AS1	5.653657731	0.033453669	Normal vs Doxo-treated	NA	NA	NA	NA	NA	CD44	SLC5A5
ENSG00000248673	LINC01331	5.964161772	0.04787461	Normal vs Doxo-treated	HSALNG0042682	integenic	Q50	NA	-	ENC1	CCL24
ENSG00000258479	LINC00640	6.529504116	0.007283804	Normal vs Doxo-treated	HSALNG0101239	integenic	Q50	hsa-miR-4430,hsa-miR-6784-5p,hsa-miR-8485	Ischemic stroke,-	TMX1	SFRP4
ENSG00000289298	ENSG00000289298	5.20863411	0.004686782	Normal vs Doxo-treated	HSALNG0126206	integenic	Not conserved	NA	NA	CEACAM4	TMEM176B
ENSG00000248975	ENSG00000248975	4.204122984	0.043418461	Normal vs Doxo-treated	HSALNG0144204	integenic	Not conserved	hsa-miR-619-5p	Nicotine dependence symptom count,Self reported educational attainment; Mathematical ability,Mathematical ability,-	PRKD1	GALNTL5
ENSG00000271984	ENSG00000271984	4.603387172	0.011542372	Normal vs Doxo-treated	HSALNG0130437	anti_sense	Q90	NA	-	NEURL2	ECM2
ENSG00000283674	ENSG00000283674	6.403651653	0.008522602	Normal vs Doxo-treated	HSALNG0063498	integenic	Not conserved	hsa-miR-1304-3p,hsa-miR-6803-5p	-	FAM86B2	BAG1
ENSG00000237166	LINC01792	3.770154893	0.047756899	Normal vs Doxo-treated	HSALNG0021489	anti_sense	Q90	hsa-miR-6756-3p	Late-onset alzheimers disease,Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,-	CLK1	P2RX1
ENSG00000259225	LINC02345	5.659882664	0.04322634	Normal vs Doxo-treated	HSALNG0105099	integenic	Not conserved	NA	NA	TMCO5A	KRT37
ENSG00000286885	ENSG00000286885	6.579159795	0.005696845	Normal vs Doxo-treated	HSALNG0048362	anti_sense	Q90	hsa-miR-320a-5p,hsa-miR-324-3p,hsa-miR-619-5p	-	NUP153	DDX5
ENSG00000251095	ENSG00000251095	5.339847491	0.000613555	Normal vs Doxo-treated	HSALNG0035787	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3187-3p,hsa-miR-6089	Body height,Lymphocyte count,Leukocyte count,Calcium measurement,Dna methylation,Stromal cell-derived factor 1 alpha measurement,Response to bupropion,Idiopathic pulmonary fibrosis,Insomnia measurement,Age at onset,Trans fatty acid measurement; Trans/cis-18:2 fatty acid measurement,Response to trauma exposure; Post-traumatic stress disorder symptom measurement,-	MMRN1	TECTA
ENSG00000258926	ENSG00000258926	5.607574897	0.002539195	Normal vs Doxo-treated	HSALNG0101770	anti_sense	Q75	NA	Gut microbiome measurement,-	TMEM30B	IL10RA
ENSG00000251301	LINC02384	5.198136907	0.010247478	Normal vs Doxo-treated	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	HPS5
ENSG00000250286	ENSG00000250286	5.199226212	0.011031839	Normal vs Doxo-treated	HSALNG0117318	anti_sense	Q75	hsa-miR-5047,hsa-miR-10394-5p	Bmi-adjusted hip circumference,-	CHAD	CLIC5
ENSG00000253438	PCAT1	8.325786091	0.000311893	Normal vs Doxo-treated	HSALNG0068395	anti_sense,sense	Q90	hsa-miR-619-5p,hsa-miR-1250-3p,hsa-miR-3652,hsa-miR-4479,hsa-miR-1587,hsa-miR-5010-5p,hsa-miR-6746-3p,hsa-miR-6826-3p,hsa-miR-6895-5p,hsa-miR-4433b-3p	Serum urea measurement,Sleep apnea measurement during rem sleep,Prostate carcinoma,Cancer,Bone density,Prostate carcinoma; Brain aneurysm,Body height,Heel bone mineral density,Lung carcinoma,Bmi-adjusted hip circumference; Prostate carcinoma,Prostate carcinoma; Cancer,Body mass index,Family history; Prostate carcinoma,Bmi-adjusted hip circumference,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Hypothyroidism,Chronic lymphocytic leukemia,Family history; Prostate cancer; Prostate carcinoma,Hypothyroidism; Autoimmune thyroid disease; Systemic lupus erythematosus; Thyroid preparation use measurement,Graves disease,Adolescent idiopathic scoliosis,Gut microbiome measurement,Bmi-adjusted waist-hip ratio,Sex hormone-binding globulin measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Prostate specific antigen measurement; Prostate carcinoma,Waist-hip ratio,Breast carcinoma; Estrogen-receptor negative breast cancer,Breast carcinoma,Rectum cancer; Polyp of colon; Cancer; Colorectal cancer; Colorectal adenoma; Prostate carcinoma,Colorectal cancer; Prostate specific antigen measurement; Prostate carcinoma,Colorectal cancer,Colorectal cancer; Colon carcinoma,Total blood protein measurement; Insomnia,Ovarian carcinoma; Breast carcinoma; Prostate carcinoma,Diabetic nephropathy; Albuminuria,Colorectal cancer; Colorectal adenoma,Multiple myeloma,-	POU5F1B	GABRG2
ENSG00000288817	ENSG00000288817	3.896631477	0.034007437	Normal vs Doxo-treated	HSALNG0136685	integenic	Q75	NA	NA	FAM9C	NPR3
ENSG00000227579	ENSG00000227579	5.656603322	0.03690938	Normal vs Doxo-treated	HSALNG0008661	integenic	Q75	hsa-miR-6764-5p	Unipolar depression,Protein measurement,Body height,Mathematical ability,Age-related macular degeneration,Abnormality of chromosome segregation,Homa-b,Mental or behavioural disorder,Sporadic amyotrophic lateral sclerosis,Ventricular enlargement measurement,Emphysema imaging measurement,Body mass index,Dna methylation,Nighttime rest measurement,Schizoaffective disorder,Cognitive function measurement,Self reported educational attainment; Mathematical ability,Susceptibility to urinary tract infection measurement,Fat body mass,Obese body mass index status,Leukocyte count,Puberty onset measurement,Body mass index; Waist circumference; Physical activity measurement; Age at menarche; Obesity,Body height; Body mass index,Body weight,Coffee consumption measurement; Body mass index,Hip circumference; Waist circumference,Age at menarche,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body mass index; Body fat percentage; Visceral adipose tissue measurement; Body height; High density lipoprotein cholesterol measurement; Grip strength measurement; Obesity; Aspartate aminotransferase measurement,Comparative body size at age 10, self-reported,Bipolar disorder; Unipolar depression,Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,Adolescent idiopathic scoliosis,-	SEC16B	AGXT2
ENSG00000275236	ENSG00000275236	3.468189448	0.049246892	Normal vs Doxo-treated	HSALNG0112671	integenic	Not conserved	NA	NA	CLEC18B	IL4
ENSG00000262714	ENSG00000262714	6.348187718	0.019260185	Normal vs Doxo-treated	HSALNG0111500	integenic	Not conserved	hsa-miR-4467,hsa-miR-3960,hsa-miR-6873-3p	Intelligence,Intelligence; Bmi-adjusted hip circumference,Waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist-hip ratio,Alkaline phosphatase measurement,Fat body mass,-	RBL2	IL4
ENSG00000230798	FOXD3-AS1	5.393568634	0.005174328	Normal vs Doxo-treated	HSALNG0004109	anti_sense	Q90	hsa-miR-654-5p,hsa-miR-1228-5p,hsa-miR-4467,hsa-miR-4650-5p,hsa-miR-4685-5p,hsa-miR-6729-5p,hsa-miR-6764-5p,hsa-miR-6784-5p,hsa-miR-6810-3p,hsa-miR-6769b-5p	-	ITGB3BP	IL4
ENSG00000272248	ENSG00000272248	4.072964369	0.039584685	Normal vs Doxo-treated	HSALNG0047688	integenic	Not conserved	NA	NA	PRPF4B	ABHD14A-ACY1
ENSG00000231131	LNCAROD	4.50683057	0.049097318	Normal vs Doxo-treated	HSALNG0078017	integenic	Not conserved	hsa-miR-6895-5p	Heel bone mineral density,Bone density; Dickkopf‐related protein 1 measurement; Heel bone mineral density,Bone density,Bone density; Heel bone mineral density,Dickkopf‐related protein 1 measurement,Femoral neck bone mineral density; Spine bone mineral density,Bone fracture,Velocity of sound measurement; Bone quantitative ultrasound measurement; Heel bone mineral density,Bone quantitative ultrasound measurement	MBL2	EHBP1
ENSG00000250166	C2CD5-AS1	5.41494892	0.049023161	Normal vs Doxo-treated	HSALNG0089827	integenic	Not conserved	hsa-miR-1202,hsa-miR-6882-5p	NA	ETNK1	TPSG1
ENSG00000260193	LINC02846	4.450946742	0.008711152	Normal vs Doxo-treated	HSALNG0075219	integenic	Q50	hsa-miR-6858-3p	NA	TMEM250	CRYZ
ENSG00000288533	ENSG00000288533	3.658587512	0.039110458	Normal vs Doxo-treated	HSALNG0145515	anti_sense	Q75	NA	-	ENOSF1	SLC8A2
ENSG00000255931	ENSG00000255931	6.113809595	0.013170448	Normal vs Doxo-treated	HSALNG0084537	integenic	Q75	hsa-miR-6824-3p,hsa-miR-6858-5p	NA	LRRC10B	VSX2
ENSG00000268066	FMR1-AS1	6.675849263	0.011232802	Normal vs Doxo-treated	HSALNG0140559	integenic	Q50	hsa-miR-4483	NA	CXorf51A	MND1
ENSG00000228526	MIR34AHG	2.285435617	0.021589597	Normal vs Doxo-treated	HSALNG0000682	integenic	Q50	hsa-miR-4279,hsa-miR-500b-3p,hsa-miR-4723-3p,hsa-miR-6724-5p,hsa-miR-6744-3p,hsa-miR-7150,hsa-miR-7152-5p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count; Aspartate aminotransferase measurement,Body height,Lean body mass,Linguistic error measurement; Specific language impairment,-	GPR157	ECHDC2
ENSG00000272079	ENSG00000272079	4.216829192	0.010537355	Normal vs Doxo-treated	HSALNG0109099	integenic	Q50	hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6089,hsa-miR-6784-5p,hsa-miR-6813-5p,hsa-miR-8072	-	NA	TRMT1L
ENSG00000260830	ENSG00000260830	3.594606784	0.049775314	Normal vs Doxo-treated	HSALNG0099880	anti_sense	Q90	hsa-miR-4539	-	RPGRIP1	GJA3
ENSG00000277287	ENSG00000277287	5.20991503	1.32e-05	Normal vs Doxo-treated	HSALNG0128242	integenic	Not conserved	NA	-	ITPA	BBS2
ENSG00000286766	ENSG00000286766	6.343167023	0.013160935	Normal vs Doxo-treated	HSALNG0150271	integenic	Q50	NA	-	OXR1	GPR18
ENSG00000287899	ENSG00000287899	5.954396412	0.024882909	Normal vs Doxo-treated	HSALNG0030707	integenic	Q90	NA	Electroencephalogram measurement,Intelligence,-	TMEM212	SRMS
ENSG00000274317	LINC02334	5.856192377	0.022494495	Normal vs Doxo-treated	HSALNG0096446	integenic	Not conserved	NA	NA	UFM1	IL37
ENSG00000233387	IATPR	5.75446019	0.028051961	Normal vs Doxo-treated	HSALNG0077173	integenic	Q50	hsa-miR-760,hsa-miR-4456	Nose morphology measurement,Serum igg glycosylation measurement,Colorectal cancer,-	NRP1	DEFB129
ENSG00000236581	STARD13-AS	7.492630191	0.000906743	Normal vs Doxo-treated	HSALNG0096264	anti_sense	Not conserved	NA	NA	KL	S1PR4
ENSG00000283839	ENSG00000283839	4.443490952	0.023928589	Normal vs Doxo-treated	HSALNG0020893	anti_sense	Q50	NA	Anxiety measurement; Depressive symptom measurement; Serum gamma-glutamyl transferase measurement; Wellbeing measurement; Bipolar disorder; Neuroticism measurement; Neurotic disorder,Wellbeing measurement; Neuroticism measurement,Neuroticism measurement; Feeling emotionally hurt measurement,-	NCKAP1	HCST
ENSG00000235724	PSMD14-DT	6.747300155	0.004481986	Normal vs Doxo-treated	HSALNG0019993	integenic	Q90	NA	Intelligence; Unipolar depression	DPP4	EDN2
ENSG00000229848	ENSG00000229848	5.74898596	0.009327433	Normal vs Doxo-treated	HSALNG0119279	anti_sense	Q50	hsa-miR-149-3p,hsa-miR-615-5p,hsa-miR-661,hsa-miR-4257,hsa-miR-4472,hsa-miR-4685-3p,hsa-miR-1199-3p,hsa-miR-6826-3p,hsa-miR-6886-5p,hsa-miR-7113-3p	Serum alanine aminotransferase measurement; Serum gamma-glutamyl transferase measurement,Sex hormone-binding globulin measurement; Serum gamma-glutamyl transferase measurement,Protein measurement,Testosterone measurement,Sex hormone-binding globulin measurement,-	FSCN2	FOXP2
ENSG00000260742	ITPRID2-DT	4.219984396	0.015252417	Normal vs Doxo-treated	HSALNG0020805	integenic	Q50	NA	NA	NEUROD1	STARD8
ENSG00000235885	LINC01828	5.784130045	0.001033389	Normal vs Doxo-treated	HSALNG0015627	integenic	Not conserved	NA	NA	ETAA1	KIF1A
ENSG00000244265	SIAH2-AS1	3.922517209	0.0492219	Normal vs Doxo-treated	HSALNG0029808	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4492,hsa-miR-6807-3p,hsa-miR-6871-5p	Breast carcinoma; Brcax breast cancer,Breast carcinoma,Brcax breast cancer,Non-alcoholic fatty liver disease severity measurement,Serum igg glycosylation measurement,Leukocyte count; Neutrophil count,Visual perception measurement,Asthma exacerbation measurement,Chronotype measurement,-	SELENOT	MTRES1
ENSG00000228061	ENSG00000228061	6.517881076	0.007099445	Normal vs Doxo-treated	HSALNG0083439	anti_sense	Not conserved	NA	NA	PAX6	BPIFA2
ENSG00000258602	LINC01629	9.97717935	7.38e-06	Normal vs Doxo-treated	HSALNG0102605	integenic	Q50	hsa-miR-505-5p,hsa-miR-1268b,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-6823-5p,hsa-miR-6858-5p,hsa-miR-6877-3p	Protein measurement,Atrial fibrillation,Total blood protein measurement; Blood protein measurement,-	LRRC74A	BPIFA2
ENSG00000276564	ENSG00000276564	5.101544335	0.007604638	Normal vs Doxo-treated	HSALNG0144681	sense	Q75	NA	-	MRTFB	TRIM47
ENSG00000261501	BBS7-DT	5.748477288	0.03690938	Normal vs Doxo-treated	HSALNG0036833	integenic	Not conserved	NA	-	EXOSC9	RAB25
ENSG00000228384	ENSG00000228384	7.336833789	0.00645161	Normal vs Doxo-treated	HSALNG0015857	anti_sense	Q75	hsa-miR-6791-5p	Serum metabolite measurement,-	ANKRD53	HAPLN2
ENSG00000226609	SNX30-DT	7.162407729	0.006107898	Normal vs Doxo-treated	HSALNG0073789	integenic	Q50	hsa-miR-619-5p	-	INIP	HAPLN2
ENSG00000288857	ENSG00000288857	4.702537404	0.019540241	Normal vs Doxo-treated	HSALNG0023391	integenic	Not conserved	hsa-miR-874-3p,hsa-miR-4482-5p	Sleep measurement,Eosinophil count,-	ILKAP	SYT6
ENSG00000283148	ENSG00000283148	5.414949406	0.049023161	Normal vs Doxo-treated	HSALNG0026404	integenic	Q75	hsa-miR-4756-5p,hsa-miR-6089	Aspartate aminotransferase measurement,Bmi-adjusted waist circumference	DNASE1L3	SYT6
ENSG00000237716	ENSG00000237716	5.948964798	0.019388676	Normal vs Doxo-treated	HSALNG0047709	integenic	Not conserved	hsa-miR-766-3p	Superior frontal gyrus volume measurement,-	ECI2	IL2RA
ENSG00000253736	ENSG00000253736	8.505853973	1.76e-10	Normal vs Doxo-treated	HSALNG0046647	integenic	Q50	NA	Cup-to-disc ratio measurement; Diastolic blood pressure; Eczema,Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration; Red blood cell distribution width,Red blood cell distribution width,-	ERGIC1	CYP2J2
ENSG00000258413	FBXO34-AS1	4.96286596	0.007638873	Normal vs Doxo-treated	HSALNG0101458	anti_sense	Q75	hsa-miR-4707-5p,hsa-miR-6763-3p,hsa-miR-6764-3p,hsa-miR-6791-3p,hsa-miR-6803-5p	Platelet count; Red blood cell distribution width,Eosinophil count,-	DLGAP5	KLB
ENSG00000285831	ENSG00000285831	4.667348877	0.010134084	Normal vs Doxo-treated	HSALNG0041776	integenic	Q50	hsa-miR-8485	Central corneal thickness,Breast carcinoma,-	MOCS2	DYSF
ENSG00000285802	ENSG00000285802	3.754912937	0.049023161	Normal vs Doxo-treated	HSALNG0001641	integenic	Q50	hsa-miR-619-5p	-	ID3	CEP350
ENSG00000205488	CALML3-AS1	6.116123455	0.013802969	Normal vs Doxo-treated	HSALNG0075870	anti_sense	Q75	hsa-miR-216a-3p,hsa-miR-500b-3p,hsa-miR-3667-3p,hsa-miR-4691-5p,hsa-miR-4734,hsa-miR-6792-5p	Cortical surface area measurement,-	CALML5	PCDH8
ENSG00000204666	ZNF473CR	5.322388554	0.005174328	Normal vs Doxo-treated	HSALNG0127074	integenic	Not conserved	NA	NA	ZNF473	SCEL
ENSG00000258583	LINC01500	5.957407049	0.030069798	Normal vs Doxo-treated	HSALNG0101652	integenic	Not conserved	NA	NA	DACT1	CCDC90B
ENSG00000235488	JARID2-AS1	5.414949172	0.049023161	Normal vs Doxo-treated	HSALNG0048272	anti_sense	Q90	hsa-miR-3960,hsa-miR-6769b-3p	-	DTNBP1	LRRC49
ENSG00000266401	ENSG00000266401	3.728675047	0.040244862	Normal vs Doxo-treated	HSALNG0119717	anti_sense	Q50	NA	Mean reticulocyte volume; Mean corpuscular volume,-	TGIF1	SLC28A2
ENSG00000235513	L3MBTL2-AS1	3.795082586	0.007638873	Normal vs Doxo-treated	HSALNG0135617	anti_sense	Q75	hsa-miR-6731-5p	Anorexia nervosa; Autism spectrum disorder; Depressive symptom measurement; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome; Neuroticism measurement,Neuroticism measurement,Breast carcinoma,Red blood cell distribution width,Mood instability measurement,Anxiety measurement; Neuroticism measurement,Depressive symptom measurement; Unipolar depression; Wellbeing measurement; Bipolar disorder; Neuroticism measurement,-	CHADL	GCOM1
ENSG00000286575	ENSG00000286575	6.028956816	0.016762958	Normal vs Doxo-treated	HSALNG0080331	anti_sense	Q50	NA	Mean corpuscular hemoglobin,Hemoglobin measurement; Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Creatine kinase measurement,Bipolar disorder; Attention deficit hyperactivity disorder; Autism spectrum disorder; Unipolar depression,Systolic blood pressure; Pulse pressure measurement; Alcohol consumption measurement; Alcohol drinking,-	CYP17A1	LHCGR
ENSG00000229167	ENSG00000229167	6.249605367	0.020205555	Normal vs Doxo-treated	HSALNG0002240	anti_sense	Q75	hsa-miR-4292,hsa-miR-6764-5p	-	PEF1	LHCGR
ENSG00000286330	ENSG00000286330	6.113809705	0.013170448	Normal vs Doxo-treated	HSALNG0097939	integenic	Q50	hsa-miR-365a-5p,hsa-miR-8485	Igf-1 measurement,Response to antidepressant,Dna methylation,Alkaline phosphatase measurement,Fev/fec ratio,Insulin sensitivity measurement; Glucose homeostasis measurement,Self reported educational attainment,Interstitial lung disease,-	UCHL3	HCN4
ENSG00000225362	CT62	5.960915085	0.005451396	Normal vs Doxo-treated	NA	NA	NA	NA	NA	THAP10	DMRTC2
ENSG00000233672	RNASEH2B-AS1	4.794341849	0.010628379	Normal vs Doxo-treated	HSALNG0097134	anti_sense	Q75	NA	Hemorrhoid,Prostate specific antigen measurement,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Mean corpuscular volume,Benign prostatic hyperplasia; Lower urinary tract symptom,-	DLEU7	CELSR2
ENSG00000251635	LINC02278	7.042104503	0.010126798	Normal vs Doxo-treated	HSALNG0033884	integenic	Q50	NA	Lymphocyte count,-	KLF3	STRA8
ENSG00000266680	ENSG00000266680	3.615935571	3.4e-05	Normal vs Doxo-treated	HSALNG0050967	anti_sense	Q75	hsa-miR-4488,hsa-miR-4734	-	EYS	NFIB
ENSG00000235609	ENSG00000235609	-3.305610271	0.038306303	Normal vs Doxo-treated	HSALNG0131973	sense	Not conserved	NA	Breast carcinoma,Age at onset; Myopia	NRIP1	INA
ENSG00000187013	LINC02875	5.417355955	0.001176109	Normal vs Doxo-treated	HSALNG0145122	integenic	Not conserved	hsa-miR-331-3p,hsa-miR-920,hsa-miR-4749-3p	Hypertension; Systolic blood pressure,-	TBX2	TIRAP
ENSG00000258457	AJUBA-DT	3.277412643	0.036069915	Normal vs Doxo-treated	HSALNG0099995	anti_sense	Q90	hsa-miR-7113-5p	Macula measurement,Gut microbiome measurement,Odontogenesis; Tooth eruption,Systolic blood pressure,Cognitive function measurement,-	PSMB11	ATPSCKMT
ENSG00000273013	ENSG00000273013	4.928843316	0.009967594	Normal vs Doxo-treated	HSALNG0031937	anti_sense	Not conserved	NA	NA	FBXO45	HHEX
ENSG00000273335	ENSG00000273335	4.614840876	0.017958021	Normal vs Doxo-treated	HSALNG0119918	anti_sense	Not conserved	NA	NA	PPP4R1	PTPRR
ENSG00000257839	PHLDA1-DT	6.378079077	0.000900617	Normal vs Doxo-treated	HSALNG0092520	anti_sense	Not conserved	NA	NA	GLIPR1	SCN3A
ENSG00000287535	ENSG00000287535	6.736893222	0.005174328	Normal vs Doxo-treated	HSALNG0064835	integenic	Not conserved	hsa-miR-744-5p,hsa-miR-6089	NA	GPAT4	LINC00467
ENSG00000234546	LNCTAM34A	3.10817482	0.013802969	Normal vs Doxo-treated	HSALNG0000685	integenic	Q50	hsa-miR-1249-5p,hsa-miR-6769b-5p,hsa-miR-7113-3p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count; Aspartate aminotransferase measurement,Lean body mass	H6PD	OXNAD1
ENSG00000234377	OBI1-AS1	4.862680002	0.010492982	Normal vs Doxo-treated	HSALNG0098080	anti_sense	Q75	hsa-miR-6855-5p	Appendicular lean mass,Body weight,Birth weight,Body height at birth,Colorectal cancer,Body height,Hematocrit; Hemoglobin measurement,Hypermetropia,Myeloid white cell count; Lymphocyte count,Creatinine measurement,Hair colour measurement,Susceptibility to urinary tract infection measurement,Brain volume measurement,Sleep duration,Protein measurement,Enuresis,Attention deficit hyperactivity disorder,Antipsychotic drug related weight gain,Response to selective serotonin reuptake inhibitor,Lip morphology measurement,Mean reticulocyte volume,Osteochondritis dissecans,Smoking status measurement,Candidemia,Carnosine measurement,Endometriosis,Squamous cell lung carcinoma,Thyroid stimulating hormone measurement,Diastolic blood pressure; Alcohol drinking,-	SLAIN1	GOLGA7B
ENSG00000257696	UHRF1BP1L-DT	4.824275471	0.011031839	Normal vs Doxo-treated	HSALNG0093431	integenic	Not conserved	NA	NA	ACTR6	PDZD9
ENSG00000254951	ENSG00000254951	5.636892483	0.021974259	Normal vs Doxo-treated	HSALNG0143125	integenic	Not conserved	NA	NA	OR5P3	CFAP161
ENSG00000289047	ENSG00000289047	3.732125256	1.6e-08	Normal vs Doxo-treated	HSALNG0049461	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4447	Manic or hypomanic episode,Lumbar disc degeneration	PSMB9	FZD1
ENSG00000237596	ENSG00000237596	4.045876248	0.022494495	Normal vs Doxo-treated	HSALNG0053689	anti_sense	Q50	hsa-miR-185-3p,hsa-miR-5572,hsa-miR-6763-5p	Hemoglobin measurement,Red blood cell distribution width,Erythrocyte count,Body height; Heel bone mineral density,Heel bone mineral density; Blood phosphate measurement,Heel bone mineral density,Age at menarche,Blood phosphate measurement,Alcoholic liver cirrhosis,Calcium measurement,Facial morphology measurement,Brcax breast cancer,Sphingomyelin 22:0 measurement,Aspartate aminotransferase measurement,Adolescent idiopathic scoliosis,Open-angle glaucoma,Glaucoma; Open-angle glaucoma; Intraocular pressure measurement,Intraocular pressure measurement,Diverticulitis,Response to corticosteroid; Response to synacthen; Cortisol measurement,Bipolar disorder; Body mass index,-	MTFR2	TAB3
ENSG00000230424	EMC1-AS1	4.355027128	0.002229174	Normal vs Doxo-treated	HSALNG0001365	anti_sense	Q50	hsa-miR-3680-5p	Alkaline phosphatase measurement,-,Brain measurement	MRTO4	FGF17
ENSG00000267439	ENSG00000267439	5.644842423	0.041661912	Normal vs Doxo-treated	HSALNG0125657	anti_sense,sense	Q90	hsa-miR-6735-5p,hsa-miR-6803-5p	Blood protein measurement,Self reported educational attainment; White matter microstructure measurement,-	HSPB6	HIPK4
ENSG00000228509	ENSG00000228509	4.741350289	0.024092039	Normal vs Doxo-treated	HSALNG0021123	anti_sense	Q50	hsa-miR-6763-5p,hsa-miR-6791-3p	Autoimmune disease; Rheumatoid arthritis; Biliary liver cirrhosis,Polymyositis,Systemic scleroderma,Femoral neck bone mineral density,Mean corpuscular hemoglobin concentration,Primary biliary cirrhosis,Heel bone mineral density,Generalised epilepsy,Chronotype measurement,Systolic blood pressure,Body height,Coronary artery disease,Self reported educational attainment,Longevity,Rheumatoid arthritis; Systemic lupus erythematosus; Myositis; Systemic scleroderma,-	STAT1	PSMC2
ENSG00000258616	LINC02303	6.486908284	0.038252575	Normal vs Doxo-treated	HSALNG0100987	integenic	Q90	NA	-	MIS18BP1	CCDC42
ENSG00000272183	ENSG00000272183	4.241407485	0.036327672	Normal vs Doxo-treated	HSALNG0016066	anti_sense	Q50	hsa-miR-4472,hsa-miR-4787-5p,hsa-miR-6836-5p	NA	TTC31	GNG3
ENSG00000272192	PDE7A-DT	3.557346459	0.040292101	Normal vs Doxo-treated	HSALNG0065858	integenic	Not conserved	hsa-miR-6510-5p,hsa-miR-6769b-3p	NA	MTFR1	OXER1
ENSG00000286048	ENSG00000286048	5.325530132	0.00090444	Normal vs Doxo-treated	HSALNG0041760	intronic_antisense	Not conserved	NA	NA	MOCS2	IL20
ENSG00000231210	COMETT	5.203999381	0.007882999	Normal vs Doxo-treated	HSALNG0060758	integenic	Not conserved	NA	NA	TFEC	FRZB
ENSG00000253891	ENSG00000253891	5.542092688	0.041829311	Normal vs Doxo-treated	HSALNG0064035	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4463,hsa-miR-4505,hsa-miR-7106-5p	Bmi-adjusted waist circumference; Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Body height,Ankylosing spondylitis,Cleft palate,Necrotizing enterocolitis,Hair colour measurement,Susceptibility to scarlet fever measurement,White matter integrity,Corneal endothelial cell measurement,Idiopathic dilated cardiomyopathy,Mathematical ability,Age at onset,Nicotine withdrawal symptom count,Pallidum volume,Myopia,Brain volume measurement,Seasonality measurement,Interleukin-6 measurement,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Myocarditis; Response to clozapine,Cingulate cortex measurement; Amyloid-beta measurement,Brain volume measurement; Neuroimaging measurement,-	STC1	DCST1
ENSG00000255521	CD44-DT	4.591757029	0.024889657	Normal vs Doxo-treated	HSALNG0083606	anti_sense	Q50	NA	Response to vitamin,-	SLC1A2	CCR1
ENSG00000286649	ENSG00000286649	5.545359609	0.047964439	Normal vs Doxo-treated	HSALNG0119855	anti_sense	Q50	NA	NA	LAMA1	FBXO40
ENSG00000280744	LINC01173	7.017153508	0.002450082	Normal vs Doxo-treated	HSALNG0023183	integenic	Not conserved	NA	Response to candesartan,Pancreatic carcinoma,Colorectal cancer,Self reported educational attainment; Systolic blood pressure,-	SH3BP4	ZNF148
ENSG00000291006	ENSG00000291006	3.849577043	1.91e-07	Normal vs Doxo-treated	NA	NA	NA	NA	NA	TMEM14A	ZNF589
ENSG00000240006	LINC02004	4.265322808	0.017386313	Normal vs Doxo-treated	HSALNG0029104	integenic	Q75	hsa-miR-619-5p,hsa-miR-4478,hsa-miR-4754,hsa-miR-6781-5p	Trauma exposure measurement,Vascular endothelial growth factor measurement,Polychlorinated biphenyls measurement,-	CEP63	CDC20B
ENSG00000282317	ENSG00000282317	6.44683659	0.016878429	Normal vs Doxo-treated	HSALNG0012102	integenic	Not conserved	NA	NA	DESI2	LINC01600
ENSG00000230623	ENSG00000230623	5.861714468	0.028051961	Normal vs Doxo-treated	HSALNG0009592	integenic	Not conserved	NA	NA	NR5A2	TP53INP1
ENSG00000125804	FAM182A	6.677913111	0.009674431	Normal vs Doxo-treated	HSALNG0129427	integenic	Not conserved	hsa-miR-483-3p,hsa-miR-619-5p,hsa-miR-2392,hsa-miR-4646-5p,hsa-miR-5787,hsa-miR-6813-5p,hsa-miR-8485	Leukocyte count,Red blood cell density measurement,Colorectal cancer; Endometrial neoplasm,-	GINS1	VEGFD
ENSG00000287367	ENSG00000287367	4.260024174	0.046605412	Normal vs Doxo-treated	HSALNG0041841	integenic	Q50	NA	-	SNX18	C11orf65
ENSG00000291038	ENSG00000291038	6.325760064	0.010625077	Normal vs Doxo-treated	NA	NA	NA	NA	NA	APEX1	C16orf46
ENSG00000230628	ENSG00000230628	5.759846743	0.028335767	Normal vs Doxo-treated	HSALNG0011625	integenic	Q75	hsa-miR-619-5p,hsa-miR-6867-3p	Cardiac arrhythmia,Reticulocyte measurement; Red blood cell distribution width,Leukocyte count,White matter hyperintensity measurement,Neutrophil count,Tinnitus; Response to cisplatin,-	IRF2BP2	C16orf46
ENSG00000255100	TSKU-AS1	4.479485035	0.009331312	Normal vs Doxo-treated	HSALNG0085880	anti_sense	Q75	NA	Vitamin d measurement,Factor vii measurement,-	LRRC32	RAB4B
ENSG00000255158	ENSG00000255158	5.542089895	0.041828943	Normal vs Doxo-treated	HSALNG0082010	anti_sense	Not conserved	NA	NA	EPS8L2	ENSG00000167774
ENSG00000231346	LINC01160	4.187110595	0.013802969	Normal vs Doxo-treated	HSALNG0006063	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4787-5p,hsa-miR-6089	Leukocyte count,Lymphocyte count,-	TMIGD3	NPIPB3
ENSG00000222005	LINC01118	6.023717983	0.02209762	Normal vs Doxo-treated	HSALNG0014712	integenic	Not conserved	NA	NA	SOCS5	CXCL8
ENSG00000246130	ENSG00000246130	3.91483395	0.018105574	Normal vs Doxo-treated	HSALNG0063955	anti_sense	Not conserved	NA	Mean corpuscular volume,Mean corpuscular volume; Mean corpuscular hemoglobin,Parasitemia measurement,-	NA	GPR183
ENSG00000275880	ENSG00000275880	3.134606325	0.014621186	Normal vs Doxo-treated	HSALNG0099381	integenic	Not conserved	hsa-miR-619-5p	NA	CARS2	AVEN
ENSG00000235300	SKAP1-AS2	5.414948702	0.049023161	Normal vs Doxo-treated	HSALNG0117086	anti_sense	Q90	hsa-miR-6764-5p	Body mass index,Endometrial carcinoma,Intelligence,Adolescent idiopathic scoliosis,Hair colour measurement,Snoring measurement,Ovarian carcinoma,-	SNX11	KCNG3
ENSG00000285492	ENSG00000285492	5.653658064	0.033453669	Normal vs Doxo-treated	HSALNG0054723	sense	Q90	hsa-miR-7160-3p	Myeloid white cell count; Celiac disease,Lipoprotein a measurement,Nicotine dependence symptom count,Autoimmune disease; Systemic lupus erythematosus; Celiac disease,Hypothyroidism,Leukocyte count,Leukocyte count; Neutrophil count,Neutrophil count; Leukocyte count; Neutrophil percentage of leukocytes; Eosinophil count; Granulocyte count,Eczema,Crohn's disease; Inflammatory bowel disease; Celiac disease,Rheumatoid arthritis; Crohn's disease,Gut microbiome measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Rheumatoid arthritis; Sclerosing cholangitis,Celiac disease,Rheumatoid arthritis,Myeloid white cell count; Neutrophil count; Basophil count,Psoriasis vulgaris,Rheumatoid arthritis; Celiac disease,Eosinophil percentage of leukocytes,-	TAGAP	KCNG3
ENSG00000286746	ENSG00000286746	5.861719108	0.028051961	Normal vs Doxo-treated	HSALNG0098203	integenic	Q90	NA	Brain volume measurement,Cortical surface area measurement,-	SPRY2	KCNG3
ENSG00000286092	ENSG00000286092	5.417914397	0.0492219	Normal vs Doxo-treated	HSALNG0094768	anti_sense	Not conserved	hsa-miR-619-5p	Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Adiponectin measurement; Body mass index,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,-	EIF2B1	KCNG3
ENSG00000255717	SNHG1	2.182532724	0.00101233	Normal vs Doxo-treated	HSALNG0084672	integenic	Q50	NA	-	WDR74	EXOSC10
ENSG00000259211	ENSG00000259211	6.630581685	0.00645161	Normal vs Doxo-treated	HSALNG0105250	anti_sense	Q90	hsa-miR-4447,hsa-miR-4802-5p	Triglyceride measurement,-	CCDC32	LGALS9C
ENSG00000286010	ENSG00000286010	4.364654991	0.014305901	Normal vs Doxo-treated	HSALNG0068436	anti_sense	Q50	hsa-miR-23a-5p,hsa-miR-619-5p,hsa-miR-4443,hsa-miR-4710	Adolescent idiopathic scoliosis,Gut microbiome measurement,Bmi-adjusted waist-hip ratio,Sex hormone-binding globulin measurement,Prostate carcinoma,Cancer,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Prostate specific antigen measurement; Prostate carcinoma,Waist-hip ratio,Breast carcinoma; Estrogen-receptor negative breast cancer,Breast carcinoma,Rectum cancer; Polyp of colon; Cancer; Colorectal cancer; Colorectal adenoma; Prostate carcinoma,Colorectal cancer; Prostate specific antigen measurement; Prostate carcinoma,Colorectal cancer,Colorectal cancer; Colon carcinoma,Prostate specific antigen measurement,Methadone dose measurement,Prostate carcinoma; Cancer,Colorectal cancer; Colorectal adenoma; Gut microbiome measurement,Body height,Corneal astigmatism,Ovarian carcinoma,Alcohol use disorder measurement,Skin pigmentation measurement,Protein measurement,Sporadic amyotrophic lateral sclerosis,Pancreatic carcinoma; Cancer,Colorectal cancer; Colorectal adenoma,Response to citalopram; Response to buspirone; Antidepressant-induced side effect; Response to antidepressant,-	LRATD2	LGALS9C
ENSG00000247095	MIR210HG	-4.282641009	0.002726245	Normal vs Doxo-treated	HSALNG0081992	anti_sense	Q50	hsa-miR-766-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6735-5p,hsa-miR-6735-3p,hsa-miR-6858-5p,hsa-miR-7843-5p	Systemic lupus erythematosus,High density lipoprotein cholesterol measurement,-	LMNTD2	CES3
ENSG00000267107	PCAT19	5.524476077	0.003935599	Normal vs Doxo-treated	HSALNG0126202	anti_sense,sense	Not conserved	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4516,hsa-miR-6089	Coronary artery disease,Angina pectoris; Myocardial infarction,Pulse pressure measurement; Coronary artery disease,Colorectal cancer; Angina pectoris,Antithrombotic agent use measurement; Aspirin use measurement,Pulse pressure measurement,Heel bone mineral density,Angina pectoris,Body weight,Red blood cell distribution width,Body height,Balding measurement,Total blood protein measurement,Blood protein measurement,Bmi-adjusted hip circumference,Testosterone measurement; Prostate carcinoma,Colorectal cancer; Colorectal adenoma,Fev/fec ratio; Response to bronchodilator,Pulse pressure measurement; Blood protein measurement,Myocardial infarction,Bmi-adjusted waist circumference; Body height,Bmi-adjusted waist circumference,-,Parental genotype effect measurement; Premature birth,Colorectal cancer; Blood protein measurement,Reticulocyte count; Reticulocyte measurement; Hair color,Body height; Bmi-adjusted hip circumference; Balding measurement	DMAC2	TLR10
ENSG00000246792	ENSG00000246792	3.479528069	0.037171881	Normal vs Doxo-treated	HSALNG0066859	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3960,hsa-miR-6089,hsa-miR-6735-5p,hsa-miR-6780a-3p,hsa-miR-6803-5p,hsa-miR-6876-5p	Protein measurement,Colorectal cancer,Agents acting on the renin-angiotensin system use measurement,Mean corpuscular volume,Chronotype measurement,Alkaline phosphatase measurement,Ejection fraction measurement,Adolescent idiopathic scoliosis,Cerebrospinal fluid clusterin measurement,Insomnia measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Response to calcium channel blocker; Cardiovascular event measurement,Bipolar disorder; Unipolar depression,-	NECAB1	CRMA
ENSG00000229081	LINC01165	6.187388897	0.011466254	Normal vs Doxo-treated	HSALNG0142899	integenic	Not conserved	hsa-miR-1304-3p,hsa-miR-4281	NA	STK32C	FGFBP3
ENSG00000230426	LINC01036	6.900035675	0.005228474	Normal vs Doxo-treated	HSALNG0009116	integenic	Q50	hsa-miR-619-5p,hsa-miR-3940-5p,hsa-miR-6802-5p	Asthma exacerbation measurement,Diet measurement,Unipolar depression,Fatty acid measurement; Fasting blood insulin measurement,Mouth morphology measurement,Non-alcoholic steatohepatitis,Protein measurement,5-hiaa measurement,Adolescent idiopathic scoliosis,Response to tenofovir,Corneal endothelial cell measurement,Interleukin 13 measurement,-	PLA2G4A	WDR49
ENSG00000263724	DLGAP1-AS3	6.126571029	0.024774158	Normal vs Doxo-treated	HSALNG0119722	anti_sense	Q75	hsa-miR-619-5p	Igfbp-3 measurement,Lysophosphatidylcholine 20:3 measurement,-	TGIF1	WDR49
ENSG00000237989	LINC01679	5.754459556	0.028051961	Normal vs Doxo-treated	HSALNG0133409	integenic	Not conserved	hsa-miR-6842-5p	Agents acting on the renin-angiotensin system use measurement,Diastolic blood pressure; Systolic blood pressure,Diastolic blood pressure,Phosphatidylcholine 38:2 measurement; Phosphatidylcholine 38:3 measurement,Bmi-adjusted waist circumference,Hair color,Systolic blood pressure,Blood pressure; Cardiovascular disease; Chronic obstructive pulmonary disease,Eye color,Cirrhosis of liver; Non-alcoholic fatty liver disease,High density lipoprotein cholesterol measurement; Metabolic syndrome,-	SIK1	ALG10B
ENSG00000177340	FLJ13224	4.865773614	0.022494495	Normal vs Doxo-treated	NA	NA	NA	NA	NA	DDX11	ENSG00000177340
ENSG00000250320	EDIL3-DT	2.315723773	0.031098387	Normal vs Doxo-treated	HSALNG0043170	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3178,hsa-miR-4505,hsa-miR-6873-3p	-	VCAN	SVBP
ENSG00000224116	INHBA-AS1	7.510291036	0.001046665	Normal vs Doxo-treated	HSALNG0057482	integenic	Not conserved	hsa-miR-6124	NA	SUGCT	RPS27
ENSG00000260641	TSPAN5-DT	3.969609263	0.032722124	Normal vs Doxo-treated	HSALNG0035964	integenic	Q50	hsa-miR-6090,hsa-miR-6769b-5p,hsa-miR-7704	Alcohol use disorder measurement,-	RAP1GDS1	GVQW3
ENSG00000180525	DIP2C-AS1	3.985629139	0.025254022	Normal vs Doxo-treated	HSALNG0075493	anti_sense,sense	Not conserved	hsa-miR-619-5p	NA	GTPBP4	DAND5
ENSG00000167912	TOX-DT	4.256256497	0.048152399	Normal vs Doxo-treated	HSALNG0065583	anti_sense	Q75	hsa-miR-1237-5p,hsa-miR-4467,hsa-miR-3960,hsa-miR-1199-5p,hsa-miR-6763-5p	-	SDCBP	MEIOC
ENSG00000288961	ENSG00000288961	3.733163112	0.019186348	Normal vs Doxo-treated	HSALNG0116727	integenic	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-4508,hsa-miR-6816-5p	-	RUNDC3A	BHLHA15
ENSG00000288805	ENSG00000288805	5.759847224	0.028335767	Normal vs Doxo-treated	HSALNG0049146	integenic	Not conserved	NA	Sarcoidosis	GNL1	LINC02363
ENSG00000285847	ENSG00000285847	5.545367123	0.047964439	Normal vs Doxo-treated	HSALNG0009013	anti_sense	Q90	hsa-miR-4505	Systolic blood pressure,-	EDEM3	LRRC75A
ENSG00000274578	ENSG00000274578	7.088766182	0.004870096	Normal vs Doxo-treated	HSALNG0120615	sense	Q90	hsa-miR-4710	NA	CDH2	KCNA4
ENSG00000229915	ENSG00000229915	4.105077279	0.020793382	Normal vs Doxo-treated	HSALNG0023432	anti_sense	Not conserved	NA	NA	PER2	ALG12
ENSG00000205611	LINC01597	5.951583711	0.021561955	Normal vs Doxo-treated	HSALNG0129452	integenic	Not conserved	hsa-miR-4433a-3p	-	DEFB116	LCK
ENSG00000223475	VOPP1-DT	7.228242451	0.002512114	Normal vs Doxo-treated	HSALNG0058196	anti_sense	Q75	NA	Eye colour measurement,-	LANCL2	GABRR3
ENSG00000250548	LINC01303	3.443823114	0.010537355	Normal vs Doxo-treated	HSALNG0101771	anti_sense	Q75	NA	Susceptibility to vaginal yeast infection measurement,Asthma exacerbation measurement,-	TMEM30B	CCR3
ENSG00000272334	ENSG00000272334	6.393392317	0.009026054	Normal vs Doxo-treated	HSALNG0025155	integenic	Not conserved	NA	NA	EPM2AIP1	TRMT12
ENSG00000254710	ENSG00000254710	6.026418141	0.019022301	Normal vs Doxo-treated	HSALNG0087814	integenic	Q75	NA	Response to radiation	GRAMD1B	MRGPRX2
ENSG00000283078	ENSG00000283078	3.720848953	0.0492219	Normal vs Doxo-treated	HSALNG0131475	anti_sense	Not conserved	hsa-miR-6826-3p,hsa-miR-6848-3p	-	LSM14B	POU3F1
ENSG00000236449	ENSG00000236449	5.762759154	0.032196047	Normal vs Doxo-treated	HSALNG0020501	anti_sense	Q75	hsa-miR-642b-5p,hsa-miR-4488,hsa-miR-6873-3p	Mean platelet volume; Platelet component distribution width,Mean platelet volume,Pulse pressure measurement; Systolic blood pressure,Atrial fibrillation,Pulse pressure measurement; Platelet component distribution width; Systolic blood pressure,Protein measurement,Resting heart rate,Agents acting on the renin-angiotensin system use measurement,Response to radiation,Qrs amplitude; Qrs complex,Forced expiratory volume; Response to bronchodilator,-	SCRN3	MORN5
ENSG00000234432	LINC02983	5.104154139	0.000856433	Normal vs Doxo-treated	HSALNG0149872	integenic	Q50	hsa-miR-4733-3p	-	TNRC18	IRS2
ENSG00000287643	ENSG00000287643	6.856130395	0.007198316	Normal vs Doxo-treated	HSALNG0102248	anti_sense	Q50	NA	Colorectal cancer,-	MAP3K9	RGS7BP
ENSG00000287781	ENSG00000287781	5.656606766	0.03690938	Normal vs Doxo-treated	HSALNG0068436	anti_sense	Q50	hsa-miR-23a-5p,hsa-miR-619-5p,hsa-miR-4443,hsa-miR-4710	Adolescent idiopathic scoliosis,Gut microbiome measurement,Bmi-adjusted waist-hip ratio,Sex hormone-binding globulin measurement,Prostate carcinoma,Cancer,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Prostate specific antigen measurement; Prostate carcinoma,Waist-hip ratio,Breast carcinoma; Estrogen-receptor negative breast cancer,Breast carcinoma,Rectum cancer; Polyp of colon; Cancer; Colorectal cancer; Colorectal adenoma; Prostate carcinoma,Colorectal cancer; Prostate specific antigen measurement; Prostate carcinoma,Colorectal cancer,Colorectal cancer; Colon carcinoma,Prostate specific antigen measurement,Methadone dose measurement,Prostate carcinoma; Cancer,Colorectal cancer; Colorectal adenoma; Gut microbiome measurement,Body height,Corneal astigmatism,Ovarian carcinoma,Alcohol use disorder measurement,Skin pigmentation measurement,Protein measurement,Sporadic amyotrophic lateral sclerosis,Pancreatic carcinoma; Cancer,Colorectal cancer; Colorectal adenoma,Response to citalopram; Response to buspirone; Antidepressant-induced side effect; Response to antidepressant,-	LRATD2	FSD2
ENSG00000203446	SUGCT-AS1	6.470010762	0.008654425	Normal vs Doxo-treated	HSALNG0057426	anti_sense	Q90	hsa-miR-6089,hsa-miR-6824-3p	-	MPLKIP	EFCAB6
ENSG00000232774	LINC03033	3.08346037	0.002687433	Normal vs Doxo-treated	HSALNG0101773	sense	Q75	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-7111-3p,hsa-miR-8485	Asthma exacerbation measurement,-	NA	NAP1L1
ENSG00000128254	YWHAH-AS1	4.241003774	0.016597574	Normal vs Doxo-treated	HSALNG0135003	anti_sense	Q75	hsa-miR-764	Lipid measurement,-	PRR14L	CARD9
ENSG00000261618	LINC02605	7.753368057	0.000880342	Normal vs Doxo-treated	HSALNG0150243	integenic	Not conserved	NA	Platelet-to-lymphocyte ratio; Lymphocyte count	ZC2HC1A	COL14A1
ENSG00000224592	MIR3659HG	10.39691261	1.48e-06	Normal vs Doxo-treated	HSALNG0002689	integenic	Not conserved	NA	NA	UTP11	COL4A5
ENSG00000224666	ETV7-AS1	7.451356147	0.001080622	Normal vs Doxo-treated	HSALNG0049748	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4674,hsa-miR-6089	Rheumatoid arthritis,Leukocyte count,Mean platelet volume,Eczema; Allergic rhinitis,-	KCTD20	SERPINA5
ENSG00000285684	ENSG00000285684	5.194521748	0.007034829	Normal vs Doxo-treated	HSALNG0098173	integenic	Q75	hsa-miR-671-5p,hsa-miR-6089	Cleft lip,Cleft lip; Oral cleft; Cleft palate,Cleft lip; Cleft palate; Progranulin measurement,Drugs used in diabetes use measurement,Diastolic blood pressure,Fev/fec ratio,Glucose measurement; Hemoglobin a1 measurement,Systolic blood pressure; Mean arterial pressure,Cleft lip; Cleft palate,-	SPRY2	SULT1C3
ENSG00000285700	ENSG00000285700	5.53308151	0.047426173	Normal vs Doxo-treated	HSALNG0108365	integenic	Q90	NA	-	MCTP2	OR2C3
ENSG00000174325	DIRC1	5.734489835	0.005527848	Normal vs Doxo-treated	HSALNG0021019	sense	Not conserved	NA	Uterine fibroid,Household income,Self reported educational attainment,Interleukin-1 beta measurement,White matter microstructure measurement,Pulse pressure measurement,-	COL5A2	H2AC13
ENSG00000249375	CASC11	4.719927195	0.010741848	Normal vs Doxo-treated	HSALNG0068468	anti_sense	Q90	hsa-miR-4707-5p	-	LRATD2	PPTC7
ENSG00000253720	ENSG00000253720	5.545362295	0.047964439	Normal vs Doxo-treated	HSALNG0068607	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6780a-3p	Rheumatoid arthritis,Post-traumatic stress disorder,-	EFR3A	CRACDL
ENSG00000229951	FOSL2-AS1	3.817294935	0.018034989	Normal vs Doxo-treated	HSALNG0013864	anti_sense	Q75	NA	Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Allergic rhinitis,Hair color,Triglyceride measurement,Hair colour measurement,Leukocyte count,-	TRMT61B	ENTPD4
ENSG00000224382	LINC00703	4.255007656	0.03222706	Normal vs Doxo-treated	HSALNG0075787	integenic	Not conserved	NA	NA	AKR1E2	FKBP1C
ENSG00000226251	LINC02608	3.773513924	0.0492219	Normal vs Doxo-treated	HSALNG0010344	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-4707-3p,hsa-miR-6773-5p,hsa-miR-7843-5p	Intelligence,Monocyte count,Hemoglobin measurement; Red blood cell density measurement; Erythrocyte count,Neutrophil percentage of leukocytes; Erythrocyte count,Body height,Granulocyte percentage of myeloid white cells; High density lipoprotein cholesterol measurement; Monocyte percentage of leukocytes,Hypermetropia,Astigmatism,Bmi-adjusted waist-hip ratio,Aspartate aminotransferase measurement,Basophil count; Basophil percentage of leukocytes,Basophil count,Self reported educational attainment,Reticulocyte count,Hair colour measurement,-	PACC1	FLVCR1-DT
ENSG00000289365	ENSG00000289365	3.442253746	0.022494495	Normal vs Doxo-treated	HSALNG0139497	integenic	Q50	NA	NA	NXT2	ZNF830
ENSG00000229425	ENSG00000229425	7.02160241	0.002228643	Normal vs Doxo-treated	HSALNG0132010	integenic	Q50	NA	NA	NRIP1	BRINP2
ENSG00000288009	ENSG00000288009	6.265894706	0.009938251	Normal vs Doxo-treated	HSALNG0051855	anti_sense	Q75	hsa-miR-4463,hsa-miR-6875-3p	Family history of lung cancer; Lung carcinoma,-	SRSF12	GPRASP3
ENSG00000276241	ENSG00000276241	8.918429094	0.001773199	Normal vs Doxo-treated	HSALNG0116009	integenic	Not conserved	NA	Visual perception measurement,C-c motif chemokine 3 measurement	CCL4	RNU4-39P
ENSG00000285820	ENSG00000285820	6.48417853	0.027966582	Normal vs Doxo-treated	HSALNG0074002	anti_sense	Q50	hsa-miR-6089,hsa-miR-6803-5p	Smoking behaviour measurement	TRIM32	E2F3P2
ENSG00000203585	LINC02408	5.765952718	0.037647634	Normal vs Doxo-treated	HSALNG0092105	integenic	Not conserved	NA	NA	DYRK2	LINC02408
ENSG00000286034	ENSG00000286034	6.540442617	1.5e-06	Normal vs Doxo-treated	HSALNG0068528	integenic	Q50	NA	Systolic blood pressure,Vital capacity,Cardiovascular disease,-	MYC	LINC00222
ENSG00000248996	PDLIM7-AS1	7.976509744	0.001315824	Normal vs Doxo-treated	HSALNG0046936	anti_sense	Q50	NA	-	PRR7	OOEP
ENSG00000274492	ENSG00000274492	5.744993702	0.046274661	Normal vs Doxo-treated	HSALNG0103052	integenic	Not conserved	NA	-	EML5	TRIM31
ENSG00000287878	ENSG00000287878	4.27139241	0.015796665	Normal vs Doxo-treated	HSALNG0024042	overlap_antisense,anti_sense	Q50	hsa-miR-1304-5p,hsa-miR-6747-3p	-	CAMK1	ENSG00000204745
ENSG00000289426	ENSG00000289426	8.052369788	6.3e-05	Normal vs Doxo-treated	HSALNG0008532	anti_sense	Q50	NA	Intelligence,-	TEX50	ENSG00000205037
ENSG00000287134	ENSG00000287134	7.011014226	0.003632483	Normal vs Doxo-treated	HSALNG0063533	anti_sense	Q75	NA	Lung carcinoma,Gas trapping measurement; Emphysema imaging measurement,Late-onset alzheimers disease,Emphysema imaging measurement,Nitric oxide exhalation measurement,-	TRMT9B	ENSG00000205037
ENSG00000232892	RGS5-AS1	7.540532682	0.000964513	Normal vs Doxo-treated	HSALNG0008045	anti_sense	Not conserved	NA	Serum alanine aminotransferase measurement,Neutrophil count,Blood lead measurement,-	NUF2	ENSG00000205037
ENSG00000286347	ENSG00000286347	5.542090003	0.041828943	Normal vs Doxo-treated	HSALNG0015723	anti_sense	Not conserved	NA	NA	GKN2	ENSG00000205037
ENSG00000290096	ENSG00000290096	3.703132131	0.043357578	Normal vs Doxo-treated	NA	NA	NA	NA	NA	RCC2	ENSG00000205037
ENSG00000262001	DLGAP1-AS2	2.952370773	0.03222706	Normal vs Doxo-treated	HSALNG0119714	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4481,hsa-miR-4505,hsa-miR-1587,hsa-miR-6089,hsa-miR-7111-5p,hsa-miR-7150	Mean corpuscular volume,Mean reticulocyte volume,Blood urea nitrogen measurement; Serum urea measurement,Fat body mass,Mean reticulocyte volume; Mean corpuscular volume,Lip morphology measurement,Alanine measurement; Amino acid measurement,-	TGIF1	CFAP44
ENSG00000260455	NBAT1	5.853626754	0.022494495	Normal vs Doxo-treated	HSALNG0048542	integenic	Q75	hsa-miR-4267,hsa-miR-4472	Neuroblastoma,Hemoglobin measurement,Hemoglobin measurement; Anilide use measurement,Hematocrit; Hemoglobin measurement; Systolic blood pressure,Neuroblastoma; Red blood cell density measurement; Mean arterial pressure,Diastolic blood pressure; Systolic blood pressure; Hemoglobin measurement; Neuroblastoma; Erythrocyte count,Hematocrit; Red blood cell density measurement,Heart rate,Complement factor h-related protein 5 measurement,Thoracic aortic aneurysm,-	PRL	KRTAP2-2
ENSG00000286695	ENSG00000286695	4.208965358	0.010563903	Normal vs Doxo-treated	HSALNG0030651	anti_sense	Q75	NA	Varicose veins	SLC7A14	GOLGA6B
ENSG00000257642	C12orf75-AS1	5.954378967	0.024774158	Normal vs Doxo-treated	HSALNG0093697	anti_sense	Not conserved	NA	-	APPL2	VPS16
ENSG00000259062	ACTN1-DT	3.980882219	0.021811899	Normal vs Doxo-treated	HSALNG0102131	anti_sense	Q75	hsa-miR-4726-3p	Mean platelet volume; Platelet count,Reticulocyte count,-	EXD2	IGSF23
ENSG00000257953	ENSG00000257953	5.522128436	0.000684444	Normal vs Doxo-treated	HSALNG0091670	anti_sense	Q75	hsa-miR-4253,hsa-miR-3667-3p	Adolescent idiopathic scoliosis,-	TSFM	BTBD10P2
ENSG00000288956	ENSG00000288956	6.091112369	0.001218121	Normal vs Doxo-treated	NA	NA	NA	NA	NA	FNBP1	ENSG00000220702
ENSG00000289170	ENSG00000289170	7.613635425	0.002277782	Normal vs Doxo-treated	NA	NA	NA	NA	NA	DUSP1	RNU6ATAC
ENSG00000224965	KCNC4-DT	4.64584313	0.017386313	Normal vs Doxo-treated	HSALNG0005961	integenic	Q90	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6132,hsa-miR-8072	Self reported educational attainment,-	ALX3	CACNA2D1-AS1
ENSG00000226985	LINC01203	6.306875636	0.00151464	Normal vs Doxo-treated	HSALNG0136702	anti_sense	Q75	hsa-miR-323b-5p,hsa-miR-4303,hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-1587,hsa-miR-499b-5p,hsa-miR-6089	Bipolar disorder	EGFL6	SMCR2
ENSG00000257474	ENSG00000257474	6.542776063	0.020156854	Normal vs Doxo-treated	HSALNG0092647	integenic	Not conserved	NA	Leukocyte count,-	SYT1	LINC02612
ENSG00000238279	ENSG00000238279	5.845122338	0.033273116	Normal vs Doxo-treated	HSALNG0007310	anti_sense	Q90	hsa-miR-4505	-	S100A1	KCTD5P1
ENSG00000272457	ENSG00000272457	4.586807675	0.01058666	Normal vs Doxo-treated	HSALNG0065335	intronic_antisense	Not conserved	NA	NA	ATP6V1H	MCCD1P2
ENSG00000244649	LINC02086	6.353755084	0.000801633	Normal vs Doxo-treated	HSALNG0117110	integenic	Not conserved	NA	Restless legs syndrome,Reading and spelling ability	PRAC2	MCCD1P2
ENSG00000232936	PANK1-AS1	4.359775812	0.016873974	Normal vs Doxo-treated	HSALNG0079589	anti_sense	Q90	hsa-miR-7108-3p	Red blood cell density measurement,-	KIF20B	ENSG00000224746
ENSG00000224875	EML4-AS1	5.95158528	0.021561955	Normal vs Doxo-treated	HSALNG0014464	anti_sense	Q75	NA	C-reactive protein measurement,-	COX7A2L	EML4-AS1
ENSG00000223770	CACNA2D1-AS1	6.268110339	0.010628379	Normal vs Doxo-treated	HSALNG0059245	anti_sense	Q75	hsa-miR-6763-5p,hsa-miR-7150,hsa-miR-8485	Sex hormone-binding globulin measurement,Gout,Sex hormone-binding globulin measurement; Endothelial growth factor measurement; Calcium measurement; Serum albumin measurement; Hepatocyte growth factor measurement,Transverse temporal cortex volume measurement,Blood protein measurement,Multiple myeloma,Cortical surface area measurement; White matter microstructure measurement,Educational attainment,Hepatocyte growth factor measurement,Headache,Sex hormone-binding globulin measurement; Serum albumin measurement,Total blood protein measurement,Testosterone measurement; Sex hormone-binding globulin measurement,Apolipoprotein b measurement,Asthma exacerbation measurement,Gestational age; Parental genotype effect measurement; Spontaneous preterm birth,-	CD36	KCNC4-DT
ENSG00000255537	ENSG00000255537	3.976971441	0.024570473	Normal vs Doxo-treated	NA	NA	NA	NA	NA	PKNOX2	PDK1-AS1
ENSG00000278330	ENSG00000278330	4.986850483	0.024181764	Normal vs Doxo-treated	HSALNG0122607	anti_sense	Not conserved	NA	-	GALR1	TGIF2P1
ENSG00000261573	ENSG00000261573	5.542088974	0.041828943	Normal vs Doxo-treated	HSALNG0009505	anti_sense	Q50	NA	Eosinophil percentage of leukocytes,Respiratory system disease,Lymphocyte count,Mean reticulocyte volume; Mean corpuscular volume,Aspartate aminotransferase measurement,Adult onset asthma,Platelet crit,-	ATP6V1G3	ENSG00000225513
ENSG00000268287	ENSG00000268287	6.196434808	0.013347198	Normal vs Doxo-treated	HSALNG0126947	anti_sense	Q75	NA	NA	CGB5	FAM225B
ENSG00000276462	LINC03025	6.356629142	0.043120483	Normal vs Doxo-treated	HSALNG0071581	integenic	Not conserved	NA	NA	FOXD4L6	TSBP1-AS1
ENSG00000246548	LINC02288	3.441332964	0.041267175	Normal vs Doxo-treated	HSALNG0102621	anti_sense	Q50	hsa-miR-615-5p,hsa-miR-4290,hsa-miR-1268b,hsa-miR-4467,hsa-miR-3960,hsa-miR-4685-3p,hsa-miR-6795-3p,hsa-miR-6838-5p	Response to anticonvulsant,Smoking status measurement; Smoking behaviour measurement,Triglyceride measurement,Feeling nervous measurement,Sleep quality; Mathematical ability,C-reactive protein measurement,Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Fev/fec ratio; Systolic blood pressure,Serum alanine aminotransferase measurement,Body weight,Serum albumin measurement,Body mass index,Smoking status measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-,Body mass index; Aspartate aminotransferase measurement	CIPC	SATB2-AS1
ENSG00000274340	ENSG00000274340	4.481385477	0.019368742	Normal vs Doxo-treated	HSALNG0106426	integenic	Q50	NA	-	C2CD4B	ENSG00000226396
ENSG00000257453	PHLDA1-AS1	3.791785061	0.049426481	Normal vs Doxo-treated	NA	NA	NA	NA	NA	GLIPR1	ENSG00000226965
ENSG00000261730	FOXF2-DT	6.641606013	0.005561861	Normal vs Doxo-treated	HSALNG0047338	anti_sense	Q50	hsa-miR-17-3p,hsa-miR-619-5p,hsa-miR-3169,hsa-miR-4308,hsa-miR-4508,hsa-miR-4763-5p,hsa-miR-5587-3p,hsa-miR-6862-3p,hsa-miR-7843-3p	Soluble triggering receptor expressed on myeloid cells 2 measurement,Age at onset,Colorectal cancer; Colorectal health,Substance abuse,Sunburn,Hair colour measurement,Protein measurement,White matter hyperintensity measurement,Cutaneous melanoma,Mosquito bite reaction size measurement,Erythema nodosum,Adolescent idiopathic scoliosis,Heel bone mineral density,Neurofibrillary tangles measurement,Colorectal mucinous adenocarcinoma,Breast carcinoma,Pancreatic carcinoma,Stroke,Cholesteryl ester 20:5 measurement,Ischemic stroke; Stroke; Small vessel stroke,Non-lobar intracerebral hemorrhage,Balding measurement,Ischemic stroke,Testosterone measurement,Bipolar disorder; Unipolar depression; Seasonality measurement,Nevus count; Cutaneous melanoma,Forced expiratory volume; Response to bronchodilator,Response to anti-thyroid drug; Drug-induced agranulocytosis,-	GMDS	LINC02798
ENSG00000260231	KDM7A-DT	3.618683466	0.003251191	Normal vs Doxo-treated	HSALNG0061777	anti_sense	Q90	NA	NA	TBXAS1	IL21-AS1
ENSG00000233977	ENSG00000233977	4.793102733	0.010911209	Normal vs Doxo-treated	HSALNG0058196	anti_sense	Q75	NA	Eye colour measurement,-	LANCL2	ENSG00000227200
ENSG00000227640	SOX21-AS1	7.132119264	0.002896566	Normal vs Doxo-treated	HSALNG0098684	integenic	Not conserved	hsa-miR-1202	NA	GPR180	SOX21-AS1
ENSG00000287763	ENSG00000287763	4.533383557	0.004697842	Normal vs Doxo-treated	HSALNG0016630	integenic	Not conserved	hsa-miR-4428	-	PLGLB1	ENSG00000227704
ENSG00000228140	EFHD2-AS1	5.754458586	0.028051961	Normal vs Doxo-treated	HSALNG0001073	anti_sense	Q50	hsa-miR-8085	Alcoholic pancreatitis,-	CASP9	RPL21P90
ENSG00000250961	RMEL3	3.110864155	0.045631355	Normal vs Doxo-treated	HSALNG0148613	integenic	Not conserved	hsa-miR-6855-5p	-	GPBP1	ENSG00000229502
ENSG00000287475	ENSG00000287475	6.733228531	0.006454919	Normal vs Doxo-treated	HSALNG0142826	integenic	Not conserved	NA	Body mass index	GRID1	ENSG00000229502
ENSG00000260034	LCMT1-AS2	5.95437437	0.024697445	Normal vs Doxo-treated	HSALNG0110336	intronic_antisense	Not conserved	NA	NA	ZKSCAN2	ENSG00000229502
ENSG00000265313	LINC01476	6.123739455	0.02052731	Normal vs Doxo-treated	HSALNG0117770	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-6809-3p	Hba1c measurement; Platelet count; Platelet crit,Platelet count,Leukocyte count,Hba1c measurement; Mean corpuscular volume; Mean corpuscular hemoglobin concentration; Red blood cell distribution width,Hemoglobin a1 measurement,Lymphocyte count; Mean corpuscular hemoglobin concentration; Platelet count; Reticulocyte count; Reticulocyte measurement,Protein measurement,Hemoglobin measurement,Blood phosphate measurement,Interleukin-1 beta measurement,-	PTRH2	ENSG00000229832
ENSG00000279855	ENSG00000279855	6.01768893	0.033453669	Normal vs Doxo-treated	HSALNG0045406	anti_sense,intronic_antisense	Q90	hsa-miR-422a	-	DIAPH1	MTAPP2
ENSG00000244578	LINC01391	4.40910208	0.023928589	Normal vs Doxo-treated	HSALNG0029310	integenic	Q50	NA	-	FOXL2	LINC02926
ENSG00000230534	ENSG00000230534	5.744993783	0.046274661	Normal vs Doxo-treated	HSALNG0077266	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4312,hsa-miR-6785-5p	Beta-nerve growth factor measurement,-	CUL2	ENSG00000230534
ENSG00000260898	ADPGK-AS1	4.52712146	0.022080667	Normal vs Doxo-treated	HSALNG0107094	anti_sense	Q75	hsa-miR-484,hsa-miR-6089,hsa-miR-6848-5p,hsa-miR-8485	Urate measurement,Grip strength measurement,Body weight,Vital capacity,Body mass index,Body mass index; Visceral adipose tissue measurement,Triglyceride measurement; Body mass index,-	BBS4	LINC02541
ENSG00000235890	TSPEAR-AS1	3.342048515	0.047777353	Normal vs Doxo-treated	HSALNG0133548	anti_sense	Not conserved	NA	Balding measurement,Alopecia,-	LRRC3	LINC02015
ENSG00000267551	GNA15-DT	4.310314277	0.009778618	Normal vs Doxo-treated	NA	NA	NA	NA	NA	TLE5	OGFOD1P1
ENSG00000258088	ENSG00000258088	4.240716271	0.038435118	Normal vs Doxo-treated	HSALNG0092503	integenic	Q75	hsa-miR-4676-5p,hsa-miR-6870-3p,hsa-miR-7703	Daytime rest measurement,Polycystic ovary syndrome,Gut microbiome measurement,Age at menopause,Serum copper measurement,Cup-to-disc ratio measurement,Bmi-adjusted waist circumference,Age at onset,Sudden cardiac arrest,Atrial fibrillation,Thyroid peroxidase antibody measurement,Central nervous system cancer,Chronic mucus hypersecretion,Blood urea nitrogen measurement; Creatinine measurement; Glomerular filtration rate,Heart rate,Aortic stenosis; Aortic valve calcification,Systolic blood pressure; Alcohol drinking,Glioma; Central nervous system cancer,Creatinine measurement; Glomerular filtration rate,-	KRR1	ENSG00000231747
ENSG00000226935	LINC00161	8.032464595	9.74e-06	Normal vs Doxo-treated	HSALNG0132500	integenic	Not conserved	NA	NA	USP16	TMEM139-AS1
ENSG00000253628	ENSG00000253628	5.162019424	0.008904779	Normal vs Doxo-treated	HSALNG0046653	integenic	Q50	hsa-miR-4463,hsa-miR-4534,hsa-miR-5190	-	ERGIC1	ENSG00000231866
ENSG00000287512	ENSG00000287512	5.938633598	0.024774158	Normal vs Doxo-treated	HSALNG0035974	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4447,hsa-miR-4534,hsa-miR-6089	Alcohol consumption measurement,Age at onset,-	METAP1	MMADHC-DT
ENSG00000287189	ENSG00000287189	6.116122076	0.013797184	Normal vs Doxo-treated	NA	NA	NA	NA	NA	CEP43	DEPDC1P2
ENSG00000254689	LINC02235	5.948964415	0.019388676	Normal vs Doxo-treated	HSALNG0066603	integenic	Not conserved	NA	Systolic blood pressure,-	CHMP4C	CYP2T1P
ENSG00000226051	ZNF503-AS1	5.545360529	0.047964439	Normal vs Doxo-treated	HSALNG0078947	integenic	Q75	hsa-miR-4430,hsa-miR-4685-3p,hsa-miR-6721-5p,hsa-miR-6779-3p,hsa-miR-6810-3p	Fev/fec ratio; Response to bronchodilator,-	VDAC2	EIF2AK3-DT
ENSG00000234203	ENSG00000234203	5.53626656	0.041414599	Normal vs Doxo-treated	HSALNG0114079	anti_sense	Q75	NA	-	ENO3	ENSG00000234203
ENSG00000258535	ENSG00000258535	6.850810812	0.004724544	Normal vs Doxo-treated	HSALNG0101253	integenic	Not conserved	hsa-miR-6089	Hippocampal atrophy,Thoracic aortic aneurysm,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Breast carcinoma,Fev/fec ratio; Response to bronchodilator,-	GNG2	PEF1-AS1
ENSG00000227431	CSE1L-DT	4.783458196	0.013616877	Normal vs Doxo-treated	HSALNG0130648	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-6089	Wellbeing measurement,-	STAU1	ENSG00000235837
ENSG00000231535	LINC00278	5.858845848	0.024285718	Normal vs Doxo-treated	HSALNG0140973	integenic	Not conserved	NA	NA	ZFY	MYCBP2-AS1
ENSG00000285966	ENSG00000285966	6.620278483	0.014470565	Normal vs Doxo-treated	HSALNG0102615	integenic	Q50	hsa-miR-1268b,hsa-miR-4463,hsa-miR-4667-3p	-	IRF2BPL	ENSG00000236114
ENSG00000224687	RASAL2-AS1	2.786093573	0.030547428	Normal vs Doxo-treated	HSALNG0008683	integenic	Q75	hsa-miR-525-3p,hsa-miR-524-3p,hsa-miR-550b-2-5p,hsa-miR-4488,hsa-miR-6509-3p	-	SEC16B	UBE2L5
ENSG00000270076	ENSG00000270076	5.207141241	0.003285157	Normal vs Doxo-treated	HSALNG0063424	anti_sense	Q90	hsa-miR-4474-3p,hsa-miR-5589-5p	Wellbeing measurement,Neuroticism measurement,White matter hyperintensity measurement; Hypertension,Diet measurement,Bone quantitative ultrasound measurement,Alkaline phosphatase measurement,Diet measurement; Mathematical ability,Heel bone mineral density,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Risk-taking behaviour,Comparative body size at age 10, self-reported,-	MTMR9	ENSG00000236457
ENSG00000260000	ENSG00000260000	3.510381212	0.03152053	Normal vs Doxo-treated	HSALNG0052248	sense	Q50	hsa-miR-4482-5p	Bipolar disorder; Unipolar depression; Risky sexual behaviour measurement,Calcium measurement,Unipolar depression,Economic and social preference,Serum albumin measurement,Smoking initiation; Smoking status measurement,Stroke outcome severity measurement,Renal system measurement,Bmi-adjusted waist circumference,Coenzyme q10 measurement,-	GRIK2	EIF1AXP1
ENSG00000251249	ENSG00000251249	5.539155313	0.039932078	Normal vs Doxo-treated	HSALNG0037877	integenic	Q75	hsa-miR-6165	-	FHIP1A	RPL24P8
ENSG00000273084	ENSG00000273084	3.283158967	0.028108474	Normal vs Doxo-treated	HSALNG0055874	anti_sense	Q50	hsa-miR-326,hsa-miR-762,hsa-miR-3195,hsa-miR-4505,hsa-miR-4632-3p,hsa-miR-5787,hsa-miR-6803-5p	Pcsk9 protein measurement,-	SLC29A4	ENSG00000237234
ENSG00000225206	MIR137HG	2.683778107	0.031521259	Normal vs Doxo-treated	HSALNG0005434	sense	Q75	NA	Feeling nervous measurement,-	DPYD	ENSG00000237481
ENSG00000259341	ENSG00000259341	6.596953998	0.01287617	Normal vs Doxo-treated	HSALNG0108542	integenic	Q50	hsa-miR-4505,hsa-miR-1587	-	TTC23	ENSG00000237525
ENSG00000238273	ENSG00000238273	7.633747082	0.006095524	Normal vs Doxo-treated	HSALNG0017579	anti_sense	Not conserved	NA	Gait measurement,Body height,-	C2orf49	ENSG00000238273
ENSG00000287787	ENSG00000287787	3.312188161	0.048426836	Normal vs Doxo-treated	HSALNG0113198	sense	Not conserved	NA	Balding measurement,Alopecia,Systolic blood pressure,Body weight,Triglyceride measurement; Response to diuretic	GSE1	RPS19P3
ENSG00000285018	ENSG00000285018	4.639796763	0.021090826	Normal vs Doxo-treated	HSALNG0151156	anti_sense	Q75	hsa-miR-665,hsa-miR-3960	NA	EMD	HLA-DOB
ENSG00000289311	ENSG00000289311	4.539770163	0.016762958	Normal vs Doxo-treated	HSALNG0093966	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4753-3p	Diastolic blood pressure; Chronic obstructive pulmonary disease; Myeloid white cell count; Myocardial infarction; Esophageal carcinoma; Mean arterial pressure; Mean corpuscular volume,Erythrocyte count,Alpha globulin measurement,Intracranial volume measurement,Calcium measurement,Virologic response measurement; Response to efavirenz,-	ANAPC7	ENSG00000241180
ENSG00000229021	ENSG00000229021	10.53909207	6.3e-07	Normal vs Doxo-treated	HSALNG0007213	anti_sense	Not conserved	NA	Atopic eczema,Susceptibility to plantar warts measurement; Vitamin d measurement; Eczema	OAZ3	RPL14P3
ENSG00000268460	ENSG00000268460	6.803467841	0.005650655	Normal vs Doxo-treated	HSALNG0126655	integenic	Not conserved	hsa-miR-550a-5p,hsa-miR-550a-3-5p,hsa-miR-1207-3p,hsa-miR-4463	-	IGFL1	RN7SL745P
ENSG00000233695	GAS6-AS1	3.745700541	0.00479704	Normal vs Doxo-treated	HSALNG0099627	anti_sense	Not conserved	hsa-miR-6721-5p	NA	TMEM255B	RAB30-DT
ENSG00000253973	NRIP3-DT	6.584750637	0.005892139	Normal vs Doxo-treated	HSALNG0082587	anti_sense	Q90	hsa-miR-4268,hsa-miR-6769b-5p	White matter hyperintensity measurement,Colorectal health,Tonsillectomy risk measurement,Waist-hip ratio,Grip strength measurement,Brain volume measurement; Neuroimaging measurement,Covid-19; Pneumonia,-	AKIP1	LRP4-AS1
ENSG00000228035	NGF-AS1	6.521769644	0.006095524	Normal vs Doxo-treated	HSALNG0006270	anti_sense	Not conserved	NA	NA	TSHB	FAM174A-DT
ENSG00000227192	ENSG00000227192	4.808247776	0.027305565	Normal vs Doxo-treated	HSALNG0054006	anti_sense	Q75	NA	Sensory perception of sweet taste,Ovarian carcinoma,Age-related nuclear cataract,Hispanic or latin american,-	HIVEP2	ENSG00000248583
ENSG00000224939	LINC00184	6.840867178	0.003299329	Normal vs Doxo-treated	HSALNG0011620	integenic	Q50	hsa-miR-885-3p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6726-5p	Balding measurement,Red blood cell distribution width,Body height,Heel bone mineral density,Health study participation,Alkaline phosphatase measurement,Lymphocyte count,Reticulocyte count; Reticulocyte measurement; Red blood cell distribution width,Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement,Eye colour measurement,Cardiac arrhythmia,Reticulocyte measurement; Red blood cell distribution width,Leukocyte count,Apolipoprotein b measurement,-	COA6	HMGB1P21
ENSG00000253408	IKBKB-DT	3.845305521	0.032852218	Normal vs Doxo-treated	HSALNG0064876	integenic	Not conserved	hsa-miR-4447,hsa-miR-6089,hsa-miR-6802-5p,hsa-miR-6891-5p,hsa-miR-1273h-5p	Systemic lupus erythematosus,-	PLAT	MTND5P11
ENSG00000182366	FAM87A	7.28790535	0.001362991	Normal vs Doxo-treated	HSALNG0062877	integenic	Not conserved	hsa-miR-4253,hsa-miR-6720-5p	Nicotine dependence symptom count,-	TDRP	THBS4-AS1
ENSG00000259720	ENSG00000259720	5.656608771	0.03690938	Normal vs Doxo-treated	HSALNG0144346	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4430	NA	FAN1	RPEP1
ENSG00000289438	ENSG00000289438	5.26911263	0.005561861	Normal vs Doxo-treated	HSALNG0149817	anti_sense	Not conserved	NA	-	AKR1D1	GLUD1P3
ENSG00000251002	TRD-AS1	4.671780524	0.014243883	Normal vs Doxo-treated	HSALNG0099951	integenic	Not conserved	hsa-miR-4505	NA	DAD1	TRD-AS1
ENSG00000259083	PNN-AS1	6.723166038	0.016469345	Normal vs Doxo-treated	HSALNG0100769	anti_sense	Q50	hsa-miR-6760-5p	-	TRAPPC6B	NIPAL4-DT
ENSG00000245293	CYP2U1-AS1	3.658588083	0.032196047	Normal vs Doxo-treated	HSALNG0036264	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-874-5p,hsa-miR-548l,hsa-miR-4328,hsa-miR-10392-3p	Monoclonal gammopathy,Protein measurement,Glycine measurement,-	LEF1	NRBF2P6
ENSG00000289319	ENSG00000289319	4.096370754	0.045668972	Normal vs Doxo-treated	HSALNG0091973	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-6791-3p	Hippocampal volume,Brain volume measurement,Sex interaction measurement; Bmi-adjusted waist-hip ratio,-	WIF1	PPIAP11
ENSG00000278041	ENSG00000278041	7.096924565	0.000146376	Normal vs Doxo-treated	HSALNG0129112	integenic	Not conserved	NA	Bone mineral content measurement	NKX2-2	ENSG00000251689
ENSG00000250497	ENSG00000250497	6.679917532	0.008210622	Normal vs Doxo-treated	HSALNG0033009	integenic	Q50	hsa-miR-181d-3p,hsa-miR-3158-3p,hsa-miR-3960,hsa-miR-5047	Facial morphology measurement,Erythrocyte count,-	BOD1L1	RNU6-1016P
ENSG00000233930	KRTAP5-AS1	5.861720228	0.028051961	Normal vs Doxo-treated	HSALNG0082122	overlap_antisense,anti_sense	Q75	hsa-miR-326,hsa-miR-4447,hsa-miR-6836-5p	Diverticular disease,Brain volume measurement,Brain volume measurement; Neuroimaging measurement,-	KRTAP5-5	LINC01170
ENSG00000235010	JAKMIP3-AS1	10.6194714	3.7e-05	Normal vs Doxo-treated	HSALNG0081756	anti_sense	Q50	hsa-miR-3178,hsa-miR-4286,hsa-miR-6784-5p,hsa-miR-6873-3p	Body mass index,-	STK32C	ENSG00000253825
ENSG00000286536	ENSG00000286536	5.542090874	0.041828943	Normal vs Doxo-treated	HSALNG0073437	integenic	Not conserved	NA	-	ABCA1	ENSG00000253965
ENSG00000227115	LINC01630	4.008778529	0.046274661	Normal vs Doxo-treated	HSALNG0121579	integenic	Q50	hsa-miR-4492,hsa-miR-4505	Apolipoprotein a 1 measurement,Calcium channel blocker use measurement,Platelet count,Platelet crit,Balding measurement,Myopia,Outer ear morphology trait; Folding of antihelix,Birth weight,Protein measurement,Sweet liking measurement,Plasma betaine measurement,Hypermetropia; Myopia,Response to beta blocker; Heart rate,Squamous cell lung carcinoma; Family history of lung cancer,-	SMAD4	ENSG00000253965
ENSG00000254038	ENSG00000254038	6.410282467	0.012340518	Normal vs Doxo-treated	HSALNG0064547	integenic	Q90	hsa-miR-4708-3p	Bipolar disorder,Insulin resistance,Breast carcinoma,Transferrin saturation measurement,-	BRF2	ENSG00000254038
ENSG00000254186	ENSG00000254186	4.255008077	0.03222706	Normal vs Doxo-treated	HSALNG0046316	integenic	Not conserved	NA	NA	NUDCD2	ENSG00000254186
ENSG00000288787	ENSG00000288787	8.157818684	0.000979152	Normal vs Doxo-treated	HSALNG0029909	integenic	Q50	hsa-miR-619-5p,hsa-miR-3162-3p,hsa-miR-6767-3p,hsa-miR-7976	Metabolically healthy obesity,Response to antineoplastic agent,Interleukin-6 measurement,Lysophosphatidylcholine 20:5 measurement,-	DHX36	ENSG00000254433
ENSG00000286672	ENSG00000286672	6.584751107	0.005893596	Normal vs Doxo-treated	HSALNG0149417	anti_sense	Not conserved	NA	NA	TMEM217	PABPC4L
ENSG00000233860	SHROOM3-AS1	6.031374223	0.015827865	Normal vs Doxo-treated	HSALNG0035321	anti_sense	Not conserved	NA	NA	SOWAHB	MAGEL2
ENSG00000269976	ENSG00000269976	6.952816949	0.024285718	Normal vs Doxo-treated	HSALNG0013447	intronic_sense	Q50	NA	-	HS1BP3	RSF1-IT2
ENSG00000245648	KLRK1-AS1	4.698187809	0.010088558	Normal vs Doxo-treated	HSALNG0089224	anti_sense	Q50	NA	Maximal oxygen uptake measurement,Nkg2-d type ii integral membrane protein measurement,-	KLRD1	ENSG00000255629
ENSG00000286655	ENSG00000286655	6.685628076	0.005561861	Normal vs Doxo-treated	HSALNG0009000	anti_sense	Q50	NA	Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,High density lipoprotein cholesterol measurement,Adolescent idiopathic scoliosis,Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,-	COLGALT2	ENSG00000255921
ENSG00000229140	CCDC26	3.837245624	0.043120483	Normal vs Doxo-treated	HSALNG0068551	integenic	Q50	hsa-miR-575,hsa-miR-619-5p,hsa-miR-885-3p,hsa-miR-4287,hsa-miR-4328,hsa-miR-3677-3p,hsa-miR-6809-3p,hsa-miR-6873-3p,hsa-miR-6892-3p,hsa-miR-8485	Dna methylation,Eczema,Balding measurement,Heel bone mineral density,Lip morphology measurement,Facial morphology measurement,Unipolar depression,Creatinine measurement,Cleft lip; Oral cleft; Cleft palate,Myeloid white cell count,Cleft lip; Progranulin measurement,Cortical surface area measurement; Cortical thickness,Alkaline phosphatase measurement,Cleft lip; Neuroimaging measurement; Heel bone mineral density; Blood phosphate measurement; Cleft palate; Brain measurement,Cleft lip; Oral cleft,Lung adenocarcinoma,Leukocyte count,Neutrophil count,Cleft lip,Eosinophil count,Vital capacity,Self reported educational attainment,Forced expiratory volume,Mathematical ability,Fev/fec ratio,Acute lymphoblastic leukemia,Body height,Monocyte count,Monocyte percentage of leukocytes,B-cell acute lymphoblastic leukemia,Gut microbiome measurement,Creatinine measurement; Glomerular filtration rate,Nicotine dependence,Glioma,Central nervous system cancer,Hypospadias,Urate measurement,Lateral occipital cortex volume measurement,Uterine fibroid,Platelet count; Platelet crit,Indole-3-propionate measurement,Bullous pemphigoid,Cortical surface area measurement,Mitochondrial dna measurement,Inflammatory bowel disease; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Monocyte count; Mean corpuscular volume,Leukocyte count; Monocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Eosinophil count; Monocyte count; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Neutrophil-to-lymphocyte ratio,Cortical thickness,Leukocyte count; Neutrophil count; Myeloid white cell count,Neutrophil percentage of leukocytes; Mean corpuscular hemoglobin,Mosaic loss of chromosome y measurement,Resistin measurement; Myeloperoxidase measurement,Lymphocyte percentage of leukocytes; Neutrophil count,Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Leukocyte count; Neutrophil count; Monocyte count,Neutrophil percentage of granulocytes; Neutrophil percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Inflammatory bowel disease; Ulcerative colitis; Monocyte count; Monocyte:lymphocyte ratio; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Adolescent idiopathic scoliosis,Monocyte count; Mean corpuscular hemoglobin concentration; Erythrocyte count,Neutrophil count; Basophil count; Leukocyte count; Eosinophil count; Granulocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Monocyte count,Erythrocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Neutrophil count; Myeloid white cell count,Red blood cell density measurement,Mean reticulocyte volume,Neutrophil percentage of leukocytes,Basophil percentage of granulocytes; Educational attainment; Basophil count; Basophil percentage of leukocytes,Granulocyte percentage of myeloid white cells,Eye color,Monocyte percentage of leukocytes; Monocyte count,Neuroimaging measurement; Glioblastoma multiforme; Glioma; White matter microstructure measurement; Brain volume measurement; Age at onset; Central nervous system cancer,Platelet count,Basophil count,Retinopathy,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Myeloid white cell count,Basophil count; Eosinophil percentage of leukocytes,Platelet crit,Eosinophil count; Eosinophil percentage of leukocytes,Response to methotrexate; Juvenile idiopathic arthritis,Cleft lip; Cleft palate,Unipolar depression; Endometriosis,Brain volume measurement; Neuroimaging measurement; Brain measurement,-	GSDMC	ENSG00000257522
ENSG00000257859	CASC18	4.940350775	0.009201077	Normal vs Doxo-treated	HSALNG0093717	integenic	Q75	hsa-miR-3679-3p,hsa-miR-6801-3p	NA	C12orf75	CASC18
ENSG00000248587	GDNF-AS1	3.747264357	0.040992528	Normal vs Doxo-treated	HSALNG0041260	integenic	Q75	NA	NA	WDR70	ENSG00000258559
ENSG00000230805	ENSG00000230805	5.653658587	0.033453669	Normal vs Doxo-treated	HSALNG0103806	integenic	Q50	hsa-miR-4447,hsa-miR-4472,hsa-miR-4486,hsa-miR-4505,hsa-miR-4508,hsa-miR-1295b-5p	Astigmatism; Body mass index,Self reported educational attainment; Body mass index,Mathematical ability,-	RTL1	ENSG00000259407
ENSG00000271926	ENSG00000271926	5.443861263	0.000534414	Normal vs Doxo-treated	HSALNG0042600	anti_sense	Q75	hsa-miR-4466,hsa-miR-3960	Serum urea measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Calcium measurement,Heel bone mineral density,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Monocyte count,Mean reticulocyte volume; Mean corpuscular volume; Serum albumin measurement,-	ZNF366	TUBAP11
ENSG00000272209	ENSG00000272209	6.10402628	0.019704156	Normal vs Doxo-treated	HSALNG0048187	anti_sense	Q50	hsa-miR-548c-5p,hsa-miR-548d-5p,hsa-miR-548o-5p,hsa-miR-548ad-5p,hsa-miR-548ae-5p,hsa-miR-548am-5p,hsa-miR-548au-5p,hsa-miR-548ay-5p,hsa-miR-548az-5p	NA	RNF182	EIF5-DT
ENSG00000259727	ENSG00000259727	4.556363195	0.0145759	Normal vs Doxo-treated	HSALNG0106445	integenic	Q50	hsa-miR-4296,hsa-miR-4496,hsa-miR-6089	-	TLN2	ENSG00000260279
ENSG00000253865	ENSG00000253865	4.206029623	0.018424554	Normal vs Doxo-treated	HSALNG0045750	anti_sense	Q50	NA	-	PCYOX1L	ENSG00000260470
ENSG00000116652	DLEU2L	3.575638751	0.036647632	Normal vs Doxo-treated	HSALNG0141784	anti_sense,sense	Q75	NA	-	EFCAB7	FAM157C
ENSG00000287712	ENSG00000287712	6.194914601	0.000856433	Normal vs Doxo-treated	HSALNG0088646	integenic	Q50	hsa-miR-4695-5p,hsa-miR-6791-3p	Glomerular filtration rate,-	TSPAN9	ENSG00000260617
ENSG00000230943	LINC02541	6.153942787	0.005852792	Normal vs Doxo-treated	HSALNG0052910	integenic	Not conserved	NA	NA	HDAC2	ADPGK-AS1
ENSG00000267327	ENSG00000267327	5.964161443	0.04787461	Normal vs Doxo-treated	HSALNG0121711	integenic	Not conserved	NA	Corneal endothelial cell measurement	WDR7	ENSG00000261451
ENSG00000261683	LINC00838	6.118519864	0.015008883	Normal vs Doxo-treated	HSALNG0077218	integenic	Q50	NA	-	PARD3	LINC00838
ENSG00000176912	TYMSOS	3.71552558	0.010897583	Normal vs Doxo-treated	HSALNG0119568	anti_sense	Not conserved	hsa-miR-6085,hsa-miR-10392-3p	-	ENOSF1	NQO1-DT
ENSG00000248371	LINC02056	5.067772644	0.009855901	Normal vs Doxo-treated	HSALNG0042592	integenic	Not conserved	NA	NA	ZNF366	MIR4777
ENSG00000260992	DOCK9-DT	3.83658647	0.016762958	Normal vs Doxo-treated	HSALNG0098888	integenic	Q50	NA	-	UBAC2	TWSG1-DT
ENSG00000259093	ENSG00000259093	4.358942469	0.024822692	Normal vs Doxo-treated	HSALNG0101816	anti_sense	Q50	NA	Endometriosis,Heel bone mineral density,Alpha ketoglutarate measurement; Maleate measurement; Fumarate measurement,Obsessive-compulsive disorder; Autism spectrum disorder,-	KCNH5	ENSG00000265474
ENSG00000260912	ENSG00000260912	3.781534217	2.48e-05	Normal vs Doxo-treated	NA	NA	NA	NA	NA	ACER2	MIR4664
ENSG00000285649	ENSG00000285649	4.818720594	0.014532997	Normal vs Doxo-treated	HSALNG0003136	anti_sense	Q50	hsa-miR-523-3p,hsa-miR-885-3p,hsa-miR-4761-3p	-	SLC6A9	ENSG00000266341
ENSG00000246877	DNM1P35	4.198203046	0.010692922	Normal vs Doxo-treated	HSALNG0107317	anti_sense	Q50	hsa-miR-4505,hsa-miR-6754-5p,hsa-miR-6784-5p	Intraocular pressure measurement,-	CSPG4	MADCAM1-AS1
ENSG00000280721	LINC01943	3.917188674	0.01948498	Normal vs Doxo-treated	HSALNG0016641	integenic	Not conserved	hsa-miR-6803-5p	-	RGPD2	CEP192-DT
ENSG00000226125	LINC01907	3.922328099	0.031521259	Normal vs Doxo-treated	HSALNG0022889	integenic	Not conserved	hsa-miR-6089	-	GPR55	ENSG00000267053
ENSG00000268658	LINC00664	5.725584982	0.003935599	Normal vs Doxo-treated	HSALNG0124901	sense	Not conserved	hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-6791-3p	Protein measurement,-	ZNF429	ATXN7L3-AS1
ENSG00000271579	ENSG00000271579	4.255007122	0.03222706	Normal vs Doxo-treated	HSALNG0094266	integenic	Not conserved	hsa-miR-4657,hsa-miR-6777-3p,hsa-miR-6852-5p	Balding measurement,Creatinine measurement,-	TBX3	HEATR6-DT
ENSG00000249738	ENSG00000249738	5.76595621	0.037713525	Normal vs Doxo-treated	HSALNG0046209	integenic	Not conserved	NA	NA	UBLCP1	ENSG00000267838
ENSG00000268108	ENSG00000268108	6.64732577	0.007562404	Normal vs Doxo-treated	HSALNG0126946	anti_sense	Not conserved	NA	NA	CGB5	ENSG00000268108
ENSG00000254275	LINC00824	7.030633714	0.003285157	Normal vs Doxo-treated	HSALNG0068532	integenic	Q50	hsa-miR-30b-3p,hsa-miR-619-5p	Systemic lupus erythematosus; Atopic eczema,Systemic lupus erythematosus,Endometrial carcinoma,Systolic blood pressure,Malignant epithelial tumor of ovary; Ovarian carcinoma,Rheumatoid arthritis,Autoimmune disease,Lung adenocarcinoma,Ovarian serous carcinoma; Ovarian carcinoma,Iron biomarker measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Celiac disease; Rheumatoid arthritis; Sclerosing cholangitis,Pancreatic carcinoma,Hypothyroidism; Autoimmune thyroid disease; Thyroid preparation use measurement,Triglyceride measurement,-	GSDMC	ENSG00000268601
ENSG00000285873	ENSG00000285873	6.995583622	0.007333326	Normal vs Doxo-treated	HSALNG0001565	anti_sense	Not conserved	NA	Bmi-adjusted hip circumference,Bmi-adjusted hip circumference; Heel bone mineral density,Endometriosis,Gestational age; Bone density; Parental genotype effect measurement	CDC42	HMGN3-AS1
ENSG00000271715	ENSG00000271715	5.861719314	0.028051961	Normal vs Doxo-treated	HSALNG0040129	integenic	Not conserved	hsa-miR-5008-3p	NA	CMBL	ENSG00000271715
ENSG00000275552	ENSG00000275552	5.834191483	0.002697346	Normal vs Doxo-treated	NA	NA	NA	NA	NA	DAD1	ENSG00000271897
ENSG00000285955	ENSG00000285955	4.248473689	0.01287617	Normal vs Doxo-treated	HSALNG0081208	anti_sense	Q50	hsa-miR-4534,hsa-miR-5693	Cognitive function measurement,Age-related macular degeneration,Systolic blood pressure,Headache,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,Refractive error,Age-related macular degeneration; Abnormality of refraction,Pulse pressure measurement; Hypertension; Diastolic blood pressure; Systolic blood pressure,Wet macular degeneration; Age-related macular degeneration,-	C10orf120	ENSG00000272108
ENSG00000272157	ENSG00000272157	8.426509904	0.000200278	Normal vs Doxo-treated	HSALNG0064061	anti_sense	Q50	NA	NA	NEFM	ENSG00000272157
ENSG00000272226	ENSG00000272226	5.935633392	0.030239259	Normal vs Doxo-treated	HSALNG0003957	integenic	Not conserved	NA	-	JUN	ENSG00000272226
ENSG00000289291	ENSG00000289291	4.668808081	0.011847668	Normal vs Doxo-treated	HSALNG0002086	anti_sense	Not conserved	hsa-miR-376a-5p,hsa-miR-1237-5p	-	TAF12	ENSG00000272555
ENSG00000289589	ENSG00000289589	5.797545822	0.008826431	Normal vs Doxo-treated	HSALNG0008846	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7108-5p	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Neuroimaging measurement; Cortical thickness; Brain measurement,-	STX6	EIF2B5-DT
ENSG00000291189	ENSG00000291189	6.055723444	0.000396606	Normal vs Doxo-treated	HSALNG0088651	integenic	Not conserved	NA	NA	CRACR2A	ENSG00000272787
ENSG00000232352	SEMA3B-AS1	7.106294435	0.00213435	Normal vs Doxo-treated	HSALNG0026010	integenic	Not conserved	hsa-miR-760,hsa-miR-4288,hsa-miR-6791-5p	NA	IFRD2	ENSG00000272829
ENSG00000270164	LINC01480	5.648015534	0.03567676	Normal vs Doxo-treated	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	ENSG00000272854
ENSG00000230838	LINC01614	3.160483027	0.038136667	Normal vs Doxo-treated	HSALNG0022084	integenic	Q50	NA	Kynurenine measurement,Bmi-adjusted waist circumference; Body height,Bmi-adjusted waist circumference,Facial width measurement,Heel bone mineral density,-	TMEM169	ENSG00000273368
ENSG00000249700	SRD5A3-AS1	3.806959849	0.031438897	Normal vs Doxo-treated	HSALNG0034531	anti_sense	Q75	hsa-miR-3929	Bmi-adjusted waist-hip ratio,Waist-hip ratio,Bmi-adjusted hip circumference,Systolic blood pressure; Aspartate aminotransferase measurement,-	CLOCK	ENSG00000273437
ENSG00000203506	RBMS3-AS2	5.861715253	0.028051961	Normal vs Doxo-treated	HSALNG0024880	anti_sense	Q75	hsa-miR-1224-3p	NA	GADL1	ENSG00000273442
ENSG00000288877	ENSG00000288877	4.489514891	0.02734133	Normal vs Doxo-treated	NA	NA	NA	NA	NA	UBTF	ENSG00000273733
ENSG00000272610	MAGI1-IT1	4.148007987	0.023373402	Normal vs Doxo-treated	HSALNG0026614	sense	Q50	NA	NA	MAGI1	LINC02970
ENSG00000231426	FILNC1	6.592655056	0.009226917	Normal vs Doxo-treated	HSALNG0053896	integenic	Q50	hsa-miR-619-5p	Serum igg glycosylation measurement,Age at onset,Response to simvastatin; Pcsk9 protein measurement,-	HECA	ENSG00000274253
ENSG00000256262	USP30-AS1	3.683270584	0.03647516	Normal vs Doxo-treated	HSALNG0093872	anti_sense	Not conserved	hsa-miR-4467,hsa-miR-3960	Platelet-to-lymphocyte ratio; Platelet count; Platelet crit,-	SVOP	ENSG00000274849
ENSG00000236914	LINC01852	3.748921652	0.032811973	Normal vs Doxo-treated	HSALNG0105101	integenic	Q90	hsa-miR-7703	Body height,-	RASGRP1	ENSG00000274922
ENSG00000222047	C10orf55	7.350071036	0.001626753	Normal vs Doxo-treated	HSALNG0078890	anti_sense,sense	Q75	NA	-	CAMK2G	ENSG00000275409
ENSG00000240350	SOCAR	5.169344288	0.005451396	Normal vs Doxo-treated	HSALNG0017893	integenic	Not conserved	NA	NA	BCL2L11	ENSG00000275703
ENSG00000267365	KCNJ2-AS1	3.956860008	0.036327672	Normal vs Doxo-treated	HSALNG0118455	anti_sense	Q50	NA	Body weight,-	ABCA5	ENSG00000276101
ENSG00000285244	DINOL	9.030388452	1.27e-06	Normal vs Doxo-treated	HSALNG0049760	anti_sense	Q50	hsa-miR-5587-3p	Electrocardiography; Pr interval; Atrial fibrillation,Protein measurement,Breast carcinoma,Ischemic stroke; Atrial fibrillation,Triglyceride measurement; Body height,-	CPNE5	LINC02809
ENSG00000246863	GPR176-DT	4.21951461	0.022581594	Normal vs Doxo-treated	HSALNG0105182	integenic	Q75	NA	-	EIF2AK4	HERC2P2
ENSG00000223711	ENSG00000223711	4.088264219	0.043249912	Normal vs Doxo-treated	HSALNG0031810	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-939-5p,hsa-miR-1237-5p,hsa-miR-4535,hsa-miR-6816-5p	-	MUC20	ENSG00000276814
ENSG00000230615	ENSG00000230615	3.293492812	0.005461128	Normal vs Doxo-treated	HSALNG0003151	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-1224-3p	-	KLF17	ENSG00000277159
ENSG00000273125	LINC01990	6.40577912	0.00939095	Normal vs Doxo-treated	HSALNG0027864	integenic	Q50	hsa-miR-665,hsa-miR-1269b	Neuroticism measurement,Body height,Prostate carcinoma,Calcium measurement,Feeling miserable measurement; Mood disorder; Unipolar depression; Neuroticism measurement; Neurotic disorder,Mood disorder; Unipolar depression,Cytokine measurement,-	CCDC54	ENSG00000277639
ENSG00000278514	ENSG00000278514	3.57270547	0.041828943	Normal vs Doxo-treated	HSALNG0108169	overlap_antisense,overlap_sense,sense	Q90	hsa-miR-4463,hsa-miR-6089	Healthspan; Balding measurement; Longevity; Parental longevity; Handedness,Neutrophil count; Apolipoprotein a 1 measurement; Hypertension; Hmg coa reductase inhibitor use measurement; Bipolar disorder; Major depressive disorder,Autism spectrum disorder; Risk-taking behaviour,Diastolic blood pressure; Mean arterial pressure; Alcohol drinking; Systolic blood pressure; Alcohol consumption measurement,Systolic blood pressure; Hypertension; Alcohol drinking,Apolipoprotein a 1 measurement,Myocardial infarction,Parental longevity,Birth weight; Myocardial infarction; Systolic blood pressure,Coronary artery disease,Hair colour measurement; Birth weight; Coronary artery disease,Pulse pressure measurement; Diastolic blood pressure; Cardiovascular disease; Alcohol drinking; Mean arterial pressure; Calcium channel blocker use measurement; Agents acting on the renin-angiotensin system use measurement; Alcohol consumption measurement,Diastolic blood pressure; Mean arterial pressure; Alcohol drinking,Leukocyte count; Systolic blood pressure,Attention deficit hyperactivity disorder,Ovarian serous carcinoma; Ovarian carcinoma; Platelet count,Platelet count; Red blood cell distribution width,Sleep duration,Red blood cell distribution width,Glucose measurement,Drugs used in diabetes use measurement; Breast carcinoma,Intelligence,Breast carcinoma; Red blood cell distribution width,Mean platelet volume; Red blood cell distribution width,Platelet count,Multisite chronic pain,Drugs used in diabetes use measurement,Hemoglobin a1 measurement,Chronic kidney disease; Hypertension; Myocardial infarction; Ischemic stroke; Coronary artery disease,-,Longevity,Hypertension; Mean arterial pressure; Systolic blood pressure; Parental longevity; Coronary artery disease,Systolic blood pressure; Alcohol drinking,Trauma exposure measurement,Birth weight,Cortical surface area measurement; Pulse pressure measurement; Coronary artery disease,Birth weight; Neutrophil count; Neuroimaging measurement; Beta blocking agent use measurement; Angina pectoris; Insomnia measurement; Brain measurement; Parental genotype effect measurement,Diuretic use measurement; Neutrophil count; Myeloid white cell count; Myocardial infarction; Angina pectoris; Antithrombotic agent use measurement,Pulse pressure measurement; Diastolic blood pressure; Hypertension; Myocardial infarction; Systolic blood pressure; Alcohol drinking; Mean arterial pressure; Coffee consumption measurement; Smoking status measurement,Pulse pressure measurement; Coronary artery disease; Balding measurement; Systolic blood pressure,Age at first sexual intercourse measurement; Childhood trauma measurement; Intelligence; Autism spectrum disorder; Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Feeling emotionally hurt measurement; Risky sexual behaviour measurement; Anorexia nervosa; Self reported educational attainment; Obsessive-compulsive disorder; Unipolar depression; Substance abuse; Risk-taking behaviour; Cortical thickness; Insomnia measurement; Tourette syndrome; Antisocial behaviour measurement,Mean corpuscular hemoglobin,Body height,Mean platelet volume	RCCD1	ENSG00000278514
ENSG00000260197	ENSG00000260197	-4.157849815	0.03340325	Normal vs Doxo-treated	HSALNG0141379	integenic	Not conserved	NA	NA	KDM5D	ENSG00000279030
ENSG00000276900	ENSG00000276900	3.335792814	0.047660388	Normal vs Doxo-treated	HSALNG0143376	anti_sense	Not conserved	hsa-miR-363-5p,hsa-miR-6089	-	ETFBKMT	ENSG00000279203
ENSG00000225174	OSTM1-AS1	5.856193141	0.022494495	Normal vs Doxo-treated	HSALNG0052553	anti_sense	Q90	hsa-miR-6813-5p	Igf-1 measurement,Astigmatism,-	NR2E1	ENSG00000279233
ENSG00000285041	ENSG00000285041	5.539155021	0.03987439	Normal vs Doxo-treated	HSALNG0141790	integenic	Not conserved	NA	NA	LRRC7	ENSG00000279982
ENSG00000259178	ENSG00000259178	4.787482076	0.011238306	Normal vs Doxo-treated	HSALNG0105951	integenic	Q50	NA	Rostral middle frontal gyrus volume measurement,Fat body mass	MAPK6	ENSG00000280159
ENSG00000229807	XIST	5.769474219	0.046605412	Normal vs Doxo-treated	HSALNG0138602	integenic	Q75	hsa-miR-8485	NA	NAP1L2	ENSG00000281706
ENSG00000179219	LINC00311	4.493981235	0.024222967	Normal vs Doxo-treated	HSALNG0113198	sense	Not conserved	NA	Balding measurement,Alopecia,Systolic blood pressure,Body weight,Triglyceride measurement; Response to diuretic	GSE1	ENSG00000283511
ENSG00000291231	ENSG00000291231	6.870200706	0.045351247	Normal vs Doxo-treated	NA	NA	NA	NA	NA	ZNF562	LINC02767
ENSG00000273674	ENSG00000273674	3.937901095	0.026212997	Normal vs Doxo-treated	HSALNG0105898	integenic	Not conserved	NA	NA	SPPL2A	TBCE
ENSG00000254231	WWP1-AS1	4.897145013	0.001843694	Normal vs Doxo-treated	HSALNG0066736	anti_sense	Not conserved	NA	Protein measurement,-	SLC7A13	TBCE
ENSG00000232098	ZNF584-DT	2.415533388	0.005749584	Normal vs Doxo-treated	HSALNG0127962	anti_sense	Not conserved	NA	Mean platelet volume,-	ZNF837	RALY-AS1
ENSG00000289034	ENSG00000289034	4.654260267	0.040602951	Normal vs Doxo-treated	HSALNG0035730	integenic	Q50	hsa-miR-6763-5p	Coffee consumption,-	ABCG2	ENSG00000285877
ENSG00000268812	LIF-AS2	6.073528836	0.001354919	Normal vs Doxo-treated	HSALNG0134872	anti_sense	Q90	hsa-miR-3178	-	HORMAD2	ENSG00000285999
ENSG00000283849	ENSG00000283849	4.987638771	0.009819781	Normal vs Doxo-treated	HSALNG0025266	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-6850-3p	Sex hormone-binding globulin measurement,Memory performance; Paragraph delayed recall measurement,-	TTC21A	ENSG00000286373
ENSG00000248243	LINC02014	8.561125102	0.000650056	Normal vs Doxo-treated	HSALNG0028934	anti_sense	Not conserved	NA	Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Total cholesterol measurement,Bmi-adjusted hip circumference,Bmi-adjusted waist-hip ratio,Creatinine measurement; Glomerular filtration rate,Sex hormone-binding globulin measurement,Body height; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,-	TMCC1	ENSG00000286535
ENSG00000289156	ENSG00000289156	7.335410617	0.007896247	Normal vs Doxo-treated	HSALNG0015684	integenic	Q75	hsa-miR-619-5p	Self reported educational attainment; Pulse pressure measurement; Intelligence; Mathematical ability; Systolic blood pressure; Cognitive function measurement; Risk-taking behaviour,-	PLEK	ENSG00000286659
ENSG00000196979	GPRACR	5.650879697	0.033202715	Normal vs Doxo-treated	HSALNG0150997	integenic	Q50	hsa-miR-6504-5p	NA	FNBP1	ENSG00000286806
ENSG00000286887	ENSG00000286887	6.675850604	0.01122556	Normal vs Doxo-treated	HSALNG0053611	anti_sense	Q50	hsa-miR-4311	Adolescent idiopathic scoliosis,Hair color; Hair colour measurement,Thyroxine measurement,-	TBPL1	ENSG00000286887
ENSG00000259370	ENSG00000259370	5.255024001	0.010194472	Normal vs Doxo-treated	HSALNG0106441	anti_sense	Q50	hsa-miR-4492	Corneal endothelial cell measurement,Body weight,Cortical surface area measurement,Cleft lip; Cleft palate; Progranulin measurement,Intracranial volume measurement,Insulin sensitivity measurement; Response to polyunsaturated fatty acid supplementation,Cleft lip; Cleft palate,-	RPS27L	ENSG00000287837
ENSG00000288103	ENSG00000288103	3.906885758	0.030655985	Normal vs Doxo-treated	HSALNG0143799	anti_sense	Not conserved	hsa-miR-3183	Sudden cardiac arrest	ATP12A	ENSG00000288103
ENSG00000286259	ENSG00000286259	7.106294689	0.00213435	Normal vs Doxo-treated	HSALNG0092509	integenic	Q50	NA	-	GLIPR1	ENSG00000288103
ENSG00000272476	ENSG00000272476	3.126001304	0.033961477	Normal vs Doxo-treated	HSALNG0052540	anti_sense	Q90	hsa-miR-504-3p,hsa-miR-4467,hsa-miR-3960	-	NR2E1	ENSG00000288827
ENSG00000253194	ENSG00000253194	5.653657775	0.033453669	Normal vs Doxo-treated	HSALNG0053116	anti_sense	Q50	NA	NA	ASF1A	ENSG00000288926
ENSG00000272382	ENSG00000272382	5.650880304	0.033166505	Normal vs Doxo-treated	HSALNG0041488	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4649-5p,hsa-miR-7108-3p	Conotruncal heart malformations	ZNF131	ENSG00000288934
ENSG00000237512	UNC5B-AS1	5.167756159	0.0016934	Normal vs Doxo-treated	HSALNG0078695	intronic_antisense	Q75	hsa-miR-619-5p,hsa-miR-939-3p,hsa-miR-1237-5p,hsa-miR-6787-3p	Attention deficit hyperactivity disorder,-	PCBD1	ENSG00000288953
ENSG00000276850	ENSG00000276850	4.608359808	0.010018491	Normal vs Doxo-treated	HSALNG0142768	integenic	Q50	NA	NA	FAM25C	ENSG00000289073
ENSG00000288951	ENSG00000288951	6.931723185	0.002774652	Normal vs Doxo-treated	HSALNG0033010	integenic	Not conserved	NA	NA	BOD1L1	ENSG00000289293
ENSG00000260588	ENSG00000260588	4.348687379	0.014745573	Normal vs Doxo-treated	HSALNG0064845	sense	Not conserved	hsa-miR-1268b	Mean reticulocyte volume	ANK1	ENSG00000289322
ENSG00000236333	TRHDE-AS1	4.716902673	0.033453669	Normal vs Doxo-treated	HSALNG0092387	anti_sense	Q50	hsa-miR-4463,hsa-miR-6782-5p,hsa-miR-6803-5p	Wellbeing measurement; Neuroticism measurement; Depressive symptom measurement,-	ZFC3H1	ENSG00000289340
ENSG00000242428	CFAP20DC-AS1	5.545366967	0.047964439	Normal vs Doxo-treated	HSALNG0026452	anti_sense	Not conserved	NA	Sleep apnea measurement,-	KCTD6	ENSG00000289347
ENSG00000289559	ENSG00000289559	4.877022481	0.011653942	Normal vs Doxo-treated	HSALNG0049460	integenic	Not conserved	NA	Lumbar disc degeneration	TAP1	ENSG00000289559
ENSG00000288007	ENSG00000288007	4.348544751	0.032196047	Normal vs Doxo-treated	HSALNG0010370	integenic	Q50	hsa-miR-4505	Loneliness measurement,Forced expiratory volume; Response to bronchodilator,-	ATF3	ENSG00000289843
ENSG00000285530	ENSG00000285530	7.026057721	0.002512114	Normal vs Doxo-treated	HSALNG0005521	anti_sense	Not conserved	NA	-	RTCA	ENSG00000289868
ENSG00000287788	ENSG00000287788	3.876275948	0.028051961	Normal vs Doxo-treated	HSALNG0065156	anti_sense	Q75	hsa-miR-485-5p	NA	PPDPFL	ENSG00000290429
ENSG00000250155	ENSG00000250155	5.65365746	0.033453669	Normal vs Doxo-treated	HSALNG0041204	anti_sense	Q75	hsa-miR-6726-5p	Alkaline phosphatase measurement,Hair colour measurement; Alkaline phosphatase measurement; Blood phosphate measurement,Heel bone mineral density,Fev/fec ratio,Unipolar depression,Aggressive periodontitis,Malaria,-	RANBP3L	ENSG00000290937
ENSG00000236283	ENSG00000236283	3.670343325	0.041717584	Normal vs Doxo-treated	HSALNG0020126	integenic	Q75	hsa-miR-6132	Functional laterality	SCN2A	ENSG00000291049
ENSG00000223382	LINC01778	4.210196895	0.008616236	Normal vs Doxo-treated	HSALNG0002198	integenic	Q90	hsa-miR-939-3p	Eye colour measurement,-	ZCCHC17	ENSG00000291054
ENSG00000225140	ENSG00000225140	5.744995832	0.046274661	Normal vs Doxo-treated	HSALNG0142487	anti_sense	Not conserved	hsa-miR-4472	NA	GTPBP4	ENSG00000291067
ENSG00000283064	ENSG00000283064	3.928254234	0.02209762	Normal vs Doxo-treated	HSALNG0048737	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Bmi-adjusted waist circumference; Body height; Bmi-adjusted waist-hip ratio,C-reactive protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Smoking status measurement; Mathematical ability,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Brain volume measurement,-	H4C4	ENSG00000291116
ENSG00000286389	ENSG00000286389	3.947315131	0.030774636	Normal vs Doxo-treated	HSALNG0011169	integenic	Not conserved	NA	-	SNAP47	ENSG00000291156
ENSG00000256092	SBNO1-AS1	3.262399722	0.025180152	Normal vs Doxo-treated	HSALNG0094721	anti_sense	Q90	hsa-miR-4508,hsa-miR-8072	Igf-1 measurement; Blood phosphate measurement,-	KMT5A	ENSG00000291174
ENSG00000246640	PICART1	3.284008127	0.007099445	Normal vs Doxo-treated	HSALNG0117242	anti_sense	Q90	hsa-miR-3178,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-10392-3p	-	SAMD14	ENSG00000291174
ENSG00000224294	PINCR	12.44428724	2.57e-08	Normal vs Doxo-treated	HSALNG0137521	integenic	Q50	hsa-miR-619-5p	NA	MAOA	ENSG00000291225
